{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:21:18Z","timestamp":1793420478298,"version":"4.5.0"},"reference-count":351,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13346-020-00818-0","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T17:05:52Z","timestamp":1596474352000},"page":"748-787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":278,"title":["Nanotechnology-based antiviral therapeutics"],"prefix":"10.1007","volume":"11","author":[{"given":"Malobika","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"818_CR1","unstructured":"Rajbari M, Rajbari N, Faridpur F. Morbidity and mortality due to Nipah or Nipah-like virus encephalitis in WHO South-East Asia Region Country: India 2018;2018. Available from: http:\/\/www.searo.who.int\/entity\/emerging_diseases\/links\/morbidity-and-mortality-nipah-sear-2001-2018.pdf."},{"key":"818_CR2","unstructured":"Immunisation Coalition 2019 Influenza statistics - Immunisation Coalition [Internet]. [cited 2019 Apr 12]. Available from: https:\/\/www.immunisationcoalition.org.au\/news-media\/2019-influenza-statistics\/"},{"key":"818_CR3","doi-asserted-by":"crossref","unstructured":"S C, Mishra AK, Bazroy J. Trend of morbidity and mortality of dengue in Tamil Nadu and Puducherry, South India. Int J Community Med Public Heal. 2017;5:322. Available from: http:\/\/www.ijcmph.com\/index.php\/ijcmph\/article\/view\/2291.","DOI":"10.18203\/2394-6040.ijcmph20175806"},{"key":"818_CR4","unstructured":"CDTR-Disease, communicable report, threats. 2018;20\u20136. Available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/Communicable-disease-threats-report-26-may-2018_0.pdf."},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"e0184492","DOI":"10.1371\/journal.pone.0184492","volume":"12","author":"E Lopez-Diez","year":"2017","unstructured":"Lopez-Diez E, Perez S, Carballo M, Inarrea A, de la Orden A, Castro M, et al. Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population. PLoS One. 2017;12:e0184492.","journal-title":"PLoS One"},{"key":"818_CR6","first-page":"1","volume":"12","author":"TL Fuller","year":"2017","unstructured":"Fuller TL, Calvet G, Estevam CG, Angelo JR, Abiodun GJ, Halai UA, et al. Behavioral, climatic, and environmental risk factors for Zika and chikungunya virus infections in Rio de Janeiro, Brazil, 2015-16. PLoS One. 2017;12:1\u201315.","journal-title":"PLoS One"},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijid.2014.02.003","volume":"25","author":"C Reker","year":"2014","unstructured":"Reker C, Islam KM. Risk factors associated with high prevalence rates of hepatitis C infection in Egypt. Int J Infect Dis. 2014;25:104\u20136. https:\/\/doi.org\/10.1016\/j.ijid.2014.02.003.","journal-title":"Int J Infect Dis"},{"key":"818_CR8","doi-asserted-by":"crossref","unstructured":"Zhu J-D, Meng W, Wang X-J, Wang H-CR. Broad-spectrum antiviral agents. Front Microbiol. 2015;6. Available from: http:\/\/www.frontiersin.org\/Virology\/10.3389\/fmicb.2015.00517\/abstract.","DOI":"10.3389\/fmicb.2015.00517"},{"key":"818_CR9","doi-asserted-by":"crossref","unstructured":"Chinchar VG. Replication of viruses. Encycl Virol [Internet]. Elsevier; 1999. p. 1471\u20138. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B0122270304002454","DOI":"10.1006\/rwvi.1999.0245"},{"key":"818_CR10","unstructured":"Baron S, Fons M AT. Viral pathogenesis medical microbiology. 4th edn. S, Baron."},{"key":"818_CR11","unstructured":"Manjarrez-zavala ME, Rosete-olvera DP, Guti\u00e9rrez-gonz\u00e1lez LH, Ocadiz-delgado R, Cabello-guti\u00e9rrez C. Pathogenesis of viral respiratory infection 2013; p. 3\u201332."},{"key":"818_CR12","doi-asserted-by":"crossref","unstructured":"Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol. 2010;10:514\u201326. Available from: http:\/\/www.nature.com\/articles\/nri2802.","DOI":"10.1038\/nri2802"},{"key":"818_CR13","doi-asserted-by":"crossref","unstructured":"Ferhadian D, Contrant M, Printz-Schweigert A, Smyth RP, Paillart J-C, Marquet R. Structural and functional motifs in influenza virus RNAs. Front Microbiol. 2018;9. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00559\/full.","DOI":"10.3389\/fmicb.2018.00559"},{"key":"818_CR14","doi-asserted-by":"publisher","unstructured":"Yan X, Wang Q, Zhang Z, Xie Y, Zhang H, Razi M, et al. Involvement of non-structural proteins (NS) in influenza A infection and viral tropism. Biochem Biophys Res Commun. Elsevier Inc.; 2012;428:62\u20137. Available from: https:\/\/doi.org\/10.1016\/j.bbrc.2012.10.006","DOI":"10.1016\/j.bbrc.2012.10.006"},{"key":"818_CR15","doi-asserted-by":"crossref","unstructured":"Cooper NJ. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;326:1235\u20131235. Available from: http:\/\/www.bmj.com\/cgi\/doi\/10.1136\/bmj.326.7401.1235.","DOI":"10.1136\/bmj.326.7401.1235"},{"key":"818_CR16","doi-asserted-by":"crossref","unstructured":"UYEKI TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J. 2003;22:164\u201377. Available from: https:\/\/insights.ovid.com\/crossref?an=00006454-200302000-00015.","DOI":"10.1097\/01.inf.0000050458.35010.b6"},{"key":"818_CR17","doi-asserted-by":"crossref","unstructured":"Dahlke C, Kasonta R, Lunemann S, Kr\u00e4hling V, Zinser ME, Biedenkopf N, et al. Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization. EBioMedicine. 2017.","DOI":"10.1016\/j.ebiom.2017.03.045"},{"key":"818_CR18","doi-asserted-by":"crossref","unstructured":"Merk A, Subramaniam S. HIV-1 envelope glycoprotein structure. Curr Opin Struct Biol. 2013;23:268\u201376. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X13000493.","DOI":"10.1016\/j.sbi.2013.03.007"},{"key":"818_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrmicro3351","volume":"12","author":"SB Laskey","year":"2014","unstructured":"Laskey SB, Siliciano RF. A mechanistic theory to explain the efficacy of antiretroviral therapy. Nat Rev Microbiol. 2014;12:772\u201380. https:\/\/doi.org\/10.1038\/nrmicro3351.","journal-title":"Nat Rev Microbiol"},{"key":"818_CR20","doi-asserted-by":"crossref","unstructured":"De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents. 2009;33:307\u201320. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908004846.","DOI":"10.1016\/j.ijantimicag.2008.10.010"},{"key":"818_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1172\/JCI200113799","volume":"108","author":"D Shukla","year":"2001","unstructured":"Shukla D, Spear PG. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest. 2001;108:503\u201310.","journal-title":"J Clin Invest"},{"key":"818_CR22","doi-asserted-by":"publisher","unstructured":"Gu M, Rice CM. Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function. Curr Opin Virol. Elsevier B.V.; 2013;3:129\u201336. Available from: https:\/\/doi.org\/10.1016\/j.coviro.2013.03.013","DOI":"10.1016\/j.coviro.2013.03.013"},{"key":"818_CR23","doi-asserted-by":"crossref","unstructured":"Sager G, Gabaglio S, Sztul E, Belov G. Role of host cell secretory machinery in zika virus life cycle. Viruses. 2018;10:559. Available from: http:\/\/www.mdpi.com\/1999-4915\/10\/10\/559","DOI":"10.3390\/v10100559"},{"key":"818_CR24","doi-asserted-by":"publisher","unstructured":"Qin C, Qi J, Gao GF. Structures of the zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe. Elsevier Inc.; 2016;1\u20139. https:\/\/doi.org\/10.1016\/j.chom.2016.04.013","DOI":"10.1016\/j.chom.2016.04.013"},{"key":"818_CR25","doi-asserted-by":"publisher","unstructured":"Reid S, Rimmer K, Thakur K. Zika virus and neurologic disease. Neurol Clin. Elsevier Inc; 2018;36:767\u201387. Available from: https:\/\/doi.org\/10.1016\/j.ncl.2018.06.003.","DOI":"10.1016\/j.ncl.2018.06.003"},{"key":"818_CR26","doi-asserted-by":"crossref","unstructured":"Guabiraba R, Ryffel B. Dengue virus infection: current concepts in immune mechanisms and lessons from murine models. Immunology. 2014;141:143\u201356. Available from: http:\/\/doi.wiley.com\/10.1111\/imm.12188.","DOI":"10.1111\/imm.12188"},{"key":"818_CR27","unstructured":"Srivastava V. Quinacrine and berberine as antiviral agents against dengue and zika fever: in silico approach. 2018;2:2016\u20139."},{"key":"818_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2018.00388","volume":"8","author":"JF Osuna-Ramos","year":"2018","unstructured":"Osuna-Ramos JF, Reyes-Ruiz JM, del \u00c1ngel RM. The role of host cholesterol during flavivirus infection. Front Cell Infect Microbiol. 2018;8:1\u201312.","journal-title":"Front Cell Infect Microbiol"},{"key":"818_CR29","doi-asserted-by":"crossref","unstructured":"Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 2020;6:14. Available from: http:\/\/www.nature.com\/articles\/s41421-020-0153-3.","DOI":"10.1038\/s41421-020-0153-3"},{"key":"818_CR30","doi-asserted-by":"crossref","unstructured":"Oshikoya KA, Ogunleye, Lawal, Senbanjo S, Oreagba. Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases. Ther Clin Risk Manag. 2013;215. Available from: http:\/\/www.dovepress.com\/clinically-significant-interactions-between-antiretroviral-and-co-pres-peer-reviewed-article-TCRM.","DOI":"10.2147\/TCRM.S44205"},{"key":"818_CR31","doi-asserted-by":"crossref","unstructured":"Gerber JG. Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection. Clin Infect Dis. 2000;30:S123\u20139. Available from: http:\/\/academic.oup.com\/cid\/article\/30\/Supplement_2\/S123\/371450\/Using-Pharmacokinetics-to-Optimize-Antiretroviral.","DOI":"10.1086\/313857"},{"key":"818_CR32","doi-asserted-by":"crossref","unstructured":"Strasfeld L, Chou S. Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin N Am. 2010;24:413\u201337. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552010000024.","DOI":"10.1016\/j.idc.2010.01.001"},{"key":"818_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","volume":"86","author":"R Singh","year":"2009","unstructured":"Singh R, Lilliard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86:215\u201323.","journal-title":"Exp Mol Pathol"},{"key":"818_CR34","doi-asserted-by":"crossref","unstructured":"Vyas SP, Subhedar R, Jain S. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. 2006;321\u2013326.","DOI":"10.1211\/jpp.58.3.0005"},{"key":"818_CR35","doi-asserted-by":"crossref","unstructured":"Chaudhuri A. Diagnosis and treatment of viral encephalitis. Postgrad Med J. 2002;78:575\u201383. Available from: http:\/\/pmj.bmj.com\/cgi\/doi\/10.1136\/pmj.78.924.575.","DOI":"10.1136\/pmj.78.924.575"},{"key":"818_CR36","doi-asserted-by":"crossref","unstructured":"Bule M, Khan F, Niaz K. Antivirals: past, present and future. Recent Adv Anim Virol. Singapore: Springer Singapore; 2019. p. 425\u201346. Available from: http:\/\/link.springer.com\/10.1007\/978-981-13-9073-9_22.","DOI":"10.1007\/978-981-13-9073-9_22"},{"key":"818_CR37","doi-asserted-by":"crossref","unstructured":"Adalja A, Inglesby T. Broad-spectrum antiviral agents: a crucial pandemic tool. Expert Rev Anti-Infect Ther. 2019;17:467\u201370. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2019.1635009.","DOI":"10.1080\/14787210.2019.1635009"},{"key":"818_CR38","doi-asserted-by":"crossref","unstructured":"Mendes PM. Cellular nanotechnology: making biological interfaces smarter. Chem Soc Rev. 2013;42:9207. Available from: http:\/\/xlink.rsc.org\/?DOI=c3cs60198f.","DOI":"10.1039\/c3cs60198f"},{"key":"818_CR39","doi-asserted-by":"publisher","first-page":"132002","DOI":"10.1088\/1361-6528\/ab5bc8","volume":"31","author":"F Villanueva-Flores","year":"2020","unstructured":"Villanueva-Flores F, Castro-Lugo A, Ram\u00edrez OT, Palomares LA. Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices. Nanotechnology. 2020;31:132002.","journal-title":"Nanotechnology."},{"key":"818_CR40","doi-asserted-by":"crossref","unstructured":"Cojocaru F-D, Botezat D, Gardikiotis I, Uritu C-M, Dodi G, Trandafir L, et al. Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics. 2020;12:171. Available from: https:\/\/www.mdpi.com\/1999-4923\/12\/2\/171.","DOI":"10.3390\/pharmaceutics12020171"},{"key":"818_CR41","doi-asserted-by":"crossref","unstructured":"Joo K-I, Lei Y, Lee C-L, Lo J, Xie J, Hamm-Alvarez SF, et al. Site-specific labeling of enveloped viruses with quantum dots for single virus tracking. ACS Nano. 2008;2:1553\u201362. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/nn8002136.","DOI":"10.1021\/nn8002136"},{"key":"818_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/0974-2077.63301","volume":"3","author":"R Saini","year":"2010","unstructured":"Saini R, Saini S, Sharma S. Nanotechnology: The future medicine. J Cutan Aesthet Surg. 2010;3:32\u20133.","journal-title":"J Cutan Aesthet Surg"},{"key":"818_CR43","doi-asserted-by":"crossref","unstructured":"Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2:395\u2013401. Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/viru.2.5.17035.","DOI":"10.4161\/viru.2.5.17035"},{"key":"818_CR44","doi-asserted-by":"crossref","unstructured":"Puri A, Loomis K, Smith B, Lee J-H, Yavlovich A, Heldman E, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26:523\u201380. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20402623.","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10"},{"key":"818_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Ray S, Thakur R. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71:349 Available from: http:\/\/www.ijpsonline.com\/text.asp?2009\/71\/4\/349\/57282.","journal-title":"Indian J Pharm Sci"},{"key":"818_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1208\/s12249-018-1284-9","volume":"20","author":"B Nabi","year":"2019","unstructured":"Nabi B, Rehman S, Baboota S, Ali J. Insights on oral drug delivery of lipid nanocarriers: a win-win solution for augmenting bioavailability of antiretroviral drugs. AAPS PharmSciTech. 2019;20:60 Available from: http:\/\/link.springer.com\/10.1208\/s12249-018-1284-9.","journal-title":"AAPS PharmSciTech"},{"key":"818_CR47","unstructured":"Attama AA, Momoh MA, Builders PF. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. Recent Adv Nov Drug Carr Syst. InTech; 2012. Available from: http:\/\/www.intechopen.com\/books\/recent-advances-in-novel-drug-carrier-systems\/lipid-nanoparticulate-drug-delivery-systems-a-revolution-in-dosage-form-design-and-development."},{"key":"818_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jconrel.2018.09.001","volume":"288","author":"T Li","year":"2018","unstructured":"Li T, Cipolla D, Rades T, Boyd BJ. Drug nanocrystallisation within liposomes. J Control Release. 2018;288:96\u2013110 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918305182.","journal-title":"J Control Release"},{"key":"818_CR49","unstructured":"He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W. Adapting liposomes for oral drug delivery. Acta Pharm Sin B. 2018; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383517307311."},{"key":"818_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ajps.2014.06.001","volume":"9","author":"Z Huang","year":"2014","unstructured":"Huang Z, Li X, Zhang T, Song Y, She Z, Li J, et al. Progress involving new techniques for liposome preparation. Asian J Pharm Sci. 2014;9:176\u201382 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087614000336.","journal-title":"Asian J Pharm Sci"},{"key":"818_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","volume":"10","author":"V Mishra","year":"2018","unstructured":"Mishra V, Bansal K, Verma A, Yadav N, Thakur S, Sudhakar K, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10:191 Available from: http:\/\/www.mdpi.com\/1999-4923\/10\/4\/191.","journal-title":"Pharmaceutics"},{"key":"818_CR52","doi-asserted-by":"publisher","unstructured":"Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. Elsevier B.V.; 2015;495:439\u201346. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.014.","DOI":"10.1016\/j.ijpharm.2015.09.014"},{"key":"818_CR53","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1038\/s41467-018-02885-x","volume":"74","author":"D Guo","year":"2017","unstructured":"Guo D, Zhou T, Ara\u00ednga M, Palandri D, Gautam N, Bronich T, et al. Creation of a long-acting nanoformulated 29,39-dideoxy-39-thiacytidine. J Acquir Immune Defic Syndr. Springer US. 2017;74:e75\u201383. https:\/\/doi.org\/10.1038\/s41467-018-02885-x.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"818_CR54","doi-asserted-by":"crossref","unstructured":"M\u00fcller RH, Alexiev U, Sinambela P, Keck CM. Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles. Percutaneous penetration enhancers chemical methods in penetration enhancement.. Dragicevic N, Maibach HI, editors. Berlin: Springer; 2016. Available from: http:\/\/link.springer.com\/10.1007\/978-3-662-47862-2","DOI":"10.1007\/978-3-662-47862-2_11"},{"key":"818_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2010.11.037","volume":"83","author":"Y-C Kuo","year":"2011","unstructured":"Kuo Y-C, Chung J-F. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surfaces B Biointerfaces. 2011;83:299\u2013306 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776510006685.","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"818_CR56","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1021\/acsomega.9b00304","volume":"4","author":"R Kanwar","year":"2019","unstructured":"Kanwar R, Rathee J, Salunke DB, Mehta SK. Green nanotechnology-driven drug delivery assemblies. ACS Omega. 2019;4:8804\u201315 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acsomega.9b00304.","journal-title":"ACS Omega"},{"key":"818_CR57","doi-asserted-by":"crossref","unstructured":"Kumar Gupta P, Bhandari N, Shah NH, Khanchandani V, Keerthana R, Nagarajan V et al. An update on nanoemulsions using nanosized liquid in liquid colloidal systems. Nanoemulsions - Prop Fabr Appl. IntechOpen; 2019. Available from: https:\/\/www.intechopen.com\/books\/nanoemulsions-properties-fabrications-and-applications\/an-update-on-nanoemulsions-using-nanosized-liquid-in-liquid-colloidal-systems.","DOI":"10.5772\/intechopen.84442"},{"key":"818_CR58","doi-asserted-by":"publisher","first-page":"12984","DOI":"10.1039\/C8RA01944D","volume":"8","author":"JJ Hobson","year":"2018","unstructured":"Hobson JJ, Edwards S, Slater RA, Martin P, Owen A, Rannard SP. Branched copolymer-stabilised nanoemulsions as new candidate oral drug delivery systems. RSC Adv. 2018;8:12984\u201391 Available from: http:\/\/xlink.rsc.org\/?DOI=C8RA01944D.","journal-title":"RSC Adv"},{"key":"818_CR59","doi-asserted-by":"crossref","unstructured":"Sutradhar KB, Amin ML. Nanoemulsions: increasing possibilities in drug delivery. Eur J Nanomed. 2013;5 Available from: https:\/\/www.degruyter.com\/view\/j\/ejnm.2013.5.issue-2\/ejnm-2013-0001\/ejnm-2013-0001.xml.","DOI":"10.1515\/ejnm-2013-0001"},{"key":"818_CR60","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1557\/adv.2018.320","volume":"3","author":"TE Manyarara","year":"2018","unstructured":"Manyarara TE, Khoza S, Dube A, Maponga CC. Formulation and characterization of a paediatric nanoemulsion dosage form with modified oral drug delivery system for improved dissolution rate of nevirapine. MRS Adv. 2018;3:2203\u201319 Available from: https:\/\/www.cambridge.org\/core\/product\/identifier\/S2059852118003201\/type\/journal_article.","journal-title":"MRS Adv"},{"key":"818_CR61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","volume":"347","author":"TK Vyas","year":"2008","unstructured":"Vyas TK, Shahiwala A, Amiji MM. Improved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm. 2008;347:93\u2013101.","journal-title":"Int J Pharm"},{"key":"818_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.apsb.2013.08.001","volume":"3","author":"K Prabhakar","year":"2013","unstructured":"Prabhakar K, Afzal SM, Surender G, Kishan V. Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharm Sin B. 2013;3:345\u201353 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383513000774.","journal-title":"Acta Pharm Sin B"},{"key":"818_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.13005\/bpj\/425","volume":"6","author":"US M","year":"2013","unstructured":"M US, Lobo FJR, Uppuluri KB. Self nano emulsifying drug delivery systems for oral delivery of hydrophobic drugs. Biomed Pharmacol J. 2013;6:355\u201362 Available from: http:\/\/www.biomedpharmajournal.org\/absdoic.php?snoid=425.","journal-title":"Biomed Pharmacol J"},{"key":"818_CR64","first-page":"23","volume":"4","author":"RP Selvam","year":"2014","unstructured":"Selvam RP, Kulkarni PK. Design and evaluation of self nanoemulsifying systems for poorly water soluble HIV drug. J PharmaSciTech. 2014;4:23\u20138 Available from: http:\/\/www.pharmascitech.in\/admin\/php\/uploads\/84_pdf.pdf.","journal-title":"J PharmaSciTech"},{"key":"818_CR65","doi-asserted-by":"crossref","unstructured":"O\u2019Keefe EP. siRNAs and shRNAs: tools for protein knockdown by gene silencing. Mater Methods. 2013;3 Available from: http:\/\/www.labome.com\/method\/siRNAs-and-shRNAs-Tools-for-Protein-Knockdown-by-Gene-Silencing.html.","DOI":"10.13070\/mm.en.3.197"},{"key":"818_CR66","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25:1467\u201375 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617301119.","journal-title":"Mol Ther"},{"key":"818_CR67","doi-asserted-by":"publisher","first-page":"16142","DOI":"10.1038\/nmicrobiol.2016.142","volume":"1","author":"EP Thi","year":"2016","unstructured":"Thi EP, Lee ACH, Geisbert JB, Ursic-Bedoya R, Agans KN, Robbins M, et al. Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nat Microbiol. 2016;1:16142 Available from: http:\/\/www.nature.com\/articles\/nmicrobiol2016142.","journal-title":"Nat Microbiol"},{"key":"818_CR68","doi-asserted-by":"publisher","unstructured":"Leung AKK, Tam YYC, Cullis PR. Lipid nanoparticles for short interfering RNA delivery. Adv Genet Elsevier; 2014. https:\/\/doi.org\/10.1016\/B978-0-12-800148-6.00004-3.","DOI":"10.1016\/B978-0-12-800148-6.00004-3"},{"key":"818_CR69","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.msec.2016.12.073","volume":"73","author":"D Nayak","year":"2017","unstructured":"Nayak D, Boxi A, Ashe S, Thathapudi NC, Nayak B. Stavudine loaded gelatin liposomes for HIV therapy: preparation, characterization and in vitro cytotoxic evaluation. Mater Sci Eng C. Elsevier B.V. 2017;73:406\u201316. https:\/\/doi.org\/10.1016\/j.msec.2016.12.073.","journal-title":"Mater Sci Eng C"},{"key":"818_CR70","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13346-011-0036-0","volume":"1","author":"S Jain","year":"2011","unstructured":"Jain S, Mistry MA, Swarnakar NK. Enhanced dermal delivery of acyclovir using solid lipid nanoparticles. Drug Deliv Transl Res. 2011;1:395\u2013406 Available from: http:\/\/link.springer.com\/10.1007\/s13346-011-0036-0.","journal-title":"Drug Deliv Transl Res"},{"key":"818_CR71","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3109\/03639045.2012.665460","volume":"39","author":"A Seyfoddin","year":"2013","unstructured":"Seyfoddin A, Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm. 2013;39:508\u201319 Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/03639045.2012.665460.","journal-title":"Drug Dev Ind Pharm"},{"key":"818_CR72","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/adhm.201300280","volume":"3","author":"TO McDonald","year":"2014","unstructured":"McDonald TO, Giardiello M, Martin P, Siccardi M, Liptrott NJ, Smith D, et al. Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation. Adv Healthc Mater. 2014;3:400\u201311 Available from: http:\/\/doi.wiley.com\/10.1002\/adhm.201300280.","journal-title":"Adv Healthc Mater"},{"key":"818_CR73","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/jphp.12716","volume":"69","author":"PR Ravi","year":"2017","unstructured":"Ravi PR, Vats R. Comparative pharmacokinetic evaluation of lopinavir and lopinavir-loaded solid lipid nanoparticles in hepatic impaired rat model. J Pharm Pharmacol. 2017;69:823\u201333.","journal-title":"J Pharm Pharmacol"},{"key":"818_CR74","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"A Khosa","year":"2018","unstructured":"Khosa A, Reddi S, Saha RN. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. 2018;103:598\u2013613 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218313222.","journal-title":"Biomed Pharmacother"},{"key":"818_CR75","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ejpb.2007.07.005","volume":"68","author":"M FENG","year":"2008","unstructured":"FENG M. Liver targeting and anti-HBV activity of reconstituted HDL\u2013acyclovir palmitate complex. Eur J Pharm Biopharm. 2008;68:688\u201393 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641107002524.","journal-title":"Eur J Pharm Biopharm"},{"key":"818_CR76","doi-asserted-by":"crossref","unstructured":"Kaushik S. Polymeric and ceramic nanoparticles: possible role in biomedical applications. Handb Polym Ceram Nanotechnol. Cham: Springer International Publishing; 2020. p. 1\u201317. Available from: http:\/\/link.springer.com\/10.1007\/978-3-030-10614-0_39-1.","DOI":"10.1007\/978-3-030-10614-0_39-1"},{"key":"818_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/nnm.09.90","volume":"5","author":"DA Chiappetta","year":"2010","unstructured":"Chiappetta DA, Hocht C, Taira C, Sosnik A. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability. Nanomedicine. 2010;5:11\u201323 Available from: https:\/\/www.futuremedicine.com\/doi\/10.2217\/nnm.09.90.","journal-title":"Nanomedicine"},{"key":"818_CR78","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.colsurfb.2014.08.011","volume":"122","author":"AJ Sawdon","year":"2014","unstructured":"Sawdon AJ, Peng C-A. Polymeric micelles for acyclovir drug delivery. Colloids Surfaces B Biointerfaces. 2014;122:738\u201345 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776514004330.","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"818_CR79","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ejps.2010.08.004","volume":"41","author":"Q Li","year":"2010","unstructured":"Li Q, Du Y-Z, Yuan H, Zhang X-G, Miao J, Cui F-D, et al. Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system. Eur J Pharm Sci. 2010;41:498\u2013507 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098710003015.","journal-title":"Eur J Pharm Sci"},{"key":"818_CR80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jddst.2018.08.020","volume":"48","author":"J Varshosaz","year":"2018","unstructured":"Varshosaz J, Taymouri S, Jafari E, Jahanian-Najafabadi A, Taheri A. Formulation and characterization of cellulose acetate butyrate nanoparticles loaded with nevirapine for HIV treatment. J Drug Deliv Sci Technol. 2018;48:9\u201320 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224718306178.","journal-title":"J Drug Deliv Sci Technol"},{"key":"818_CR81","doi-asserted-by":"publisher","unstructured":"Martins C, Ara\u00fajo F, Gomes MJ, Fernandes C, Nunes R, Li W, et al. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy. Eur J Pharm Biopharm. Elsevier; 2018;0\u20131. https:\/\/doi.org\/10.1016\/j.ejpb.2018.01.014","DOI":"10.1016\/j.ejpb.2018.01.014"},{"key":"818_CR82","first-page":"IDRT.S38108","volume":"9","author":"O Ogunwuyi","year":"2016","unstructured":"Ogunwuyi O, Kumari N, Smith KA, Bolshakov O, Adesina S, Gugssa A, et al. Antiretroviral drugs-loaded nanoparticles fabricated by dispersion polymerization with potential for HIV\/AIDS treatment. Infect Dis Res Treat. 2016;9:IDRT.S38108 Available from: http:\/\/journals.sagepub.com\/doi\/10.4137\/IDRT.S38108.","journal-title":"Infect Dis Res Treat"},{"key":"818_CR83","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.colsurfb.2011.11.007","volume":"91","author":"Y-C Kuo","year":"2012","unstructured":"Kuo Y-C, Chung C-Y. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. Colloids Surfaces B Biointerfaces. 2012;91:242\u20139 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776511006527.","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"818_CR84","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.3390\/md13085156","volume":"13","author":"R Cheung","year":"2015","unstructured":"Cheung R, Ng T, Wong J, Chan W. Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs. 2015;13:5156\u201386 Available from: http:\/\/www.mdpi.com\/1660-3397\/13\/8\/5156.","journal-title":"Mar Drugs"},{"key":"818_CR85","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1469-0691.2006.01372.x","volume":"12","author":"P Panagopoulos","year":"2006","unstructured":"Panagopoulos P, Tsiodras S, Antoniadou A, Katsarolis I, Papadopoulos A, Poulakou G, et al. Efficacy and safety of an anti-retroviral combination regimen including either efavirenz or lopinavir\u2013ritonavir with a backbone of two nucleoside reverse transcriptase inhibitors. Clin Microbiol Infect. 2006;12:486\u20139 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14620164.","journal-title":"Clin Microbiol Infect"},{"key":"818_CR86","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jddst.2018.06.006","volume":"47","author":"DM Dhoke","year":"2018","unstructured":"Dhoke DM, Basaiyye SS, Khedekar PB. Development and characterization of L-HSA conjugated PLGA nanoparticle for hepatocyte targeted delivery of antiviral drug. J Drug Deliv Sci Technol. 2018;47:77\u201394 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224718303496.","journal-title":"J Drug Deliv Sci Technol"},{"key":"818_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbrep.2017.10.005","volume":"12","author":"Y Gong","year":"2017","unstructured":"Gong Y, Chowdhury P, Midde NM, Rahman MA, Yallapu MM, Kumar S. Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages. Biochem Biophys Reports. Elsevier B.V. 2017;12:214\u20139. https:\/\/doi.org\/10.1016\/j.bbrep.2017.10.005.","journal-title":"Biochem Biophys Reports"},{"key":"818_CR88","unstructured":"Alka S. Development and evaluation of cyclodextrin based nanosponges for bioavailability enhancement of poorly bioavailable drug. World Jornal of Pharmacy and Pharmaceutical Sciences. 2017;6:805\u201336."},{"key":"818_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4591634","volume":"2016","author":"H Hassan","year":"2016","unstructured":"Hassan H, Adam SK, Othman F, Shamsuddin AF, Basir R. Antiviral nanodelivery systems: current trends in acyclovir administration. J Nanomater. 2016;2016:1\u20138 Available from: https:\/\/www.hindawi.com\/journals\/jnm\/2016\/4591634\/.","journal-title":"J Nanomater"},{"key":"818_CR90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13346-014-0191-1","volume":"4","author":"A Patel","year":"2014","unstructured":"Patel A, Shelat P, Lalwani A. Development and optimization of solid self-nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe\u2019s design for improvement of oral bioavailability of nelfinavir mesylate. Drug Deliv Transl Res. 2014;4:171\u201386 Available from: http:\/\/link.springer.com\/10.1007\/s13346-014-0191-1.","journal-title":"Drug Deliv Transl Res"},{"key":"818_CR91","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1208\/s12249-008-9180-3","volume":"10","author":"S Sathigari","year":"2009","unstructured":"Sathigari S, Chadha G, Lee Y-HP, Wright N, Parsons DL, Rangari VK, et al. Physicochemical characterization of efavirenz\u2013cyclodextrin inclusion complexes. AAPS PharmSciTech. 2009;10:81\u20137 Available from: http:\/\/www.springerlink.com\/index\/10.1208\/s12249-008-9180-3.","journal-title":"AAPS PharmSciTech"},{"key":"818_CR92","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang Y-Y, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61:158\u201371 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X08002652.","journal-title":"Adv Drug Deliv Rev"},{"key":"818_CR93","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cossms.2012.10.004","volume":"16","author":"B Sun","year":"2012","unstructured":"Sun B, Yeo Y. Nanocrystals for the parenteral delivery of poorly water-soluble drugs. Curr Opin Solid State Mater Sci. 2012;16:295\u2013301 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135902861200054X.","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"818_CR94","doi-asserted-by":"crossref","unstructured":"Kaur G, Aggarwal G, Harikumar SL. Nanosponge: new colloidal drug delivery system for topical delivery. Indo Global J Pharm Sci. 2015;5:53\u20137.","DOI":"10.35652\/IGJPS.2015.23"},{"key":"818_CR95","doi-asserted-by":"crossref","unstructured":"Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: a review. Acta Pharm. 2013;63:335\u201358.","DOI":"10.2478\/acph-2013-0021"},{"key":"818_CR96","doi-asserted-by":"publisher","unstructured":"Pothen LA, Thomas S. Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery. Int J Biol Macromol. Elsevier B.V.; 2017. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.09.078","DOI":"10.1016\/j.ijbiomac.2017.09.078"},{"key":"818_CR97","doi-asserted-by":"publisher","unstructured":"Ratemi E. pH-responsive polymers for drug delivery applications. Stimuli Responsive Polym. Nanocarriers Drug Deliv. Appl. Vol. 1 Types Triggers. Elsevier Ltd.; 2018. https:\/\/doi.org\/10.1016\/B978-0-08-101997-9.00005-9","DOI":"10.1016\/B978-0-08-101997-9.00005-9"},{"key":"818_CR98","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jpha.2014.09.002","volume":"5","author":"VV Bhaskar","year":"2015","unstructured":"Bhaskar VV, Middha A, Srivastava P, Rajagopal S. Liquid chromatography\/tandem mass spectrometry method for quantitative estimation of solutol HS15 and its applications. J Pharm Anal. 2015;5:120\u20139 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177914000835.","journal-title":"J Pharm Anal"},{"key":"818_CR99","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12668-012-0060-7","volume":"2","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dilbaghi N, Saharan R, Bhanjana G. Nanotechnology as emerging tool for enhancing solubility of poorly water-soluble drugs. Bionanoscience. 2012;2:227\u201350.","journal-title":"Bionanoscience."},{"key":"818_CR100","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","volume":"118","author":"H Cabral","year":"2018","unstructured":"Cabral H, Miyata K, Osada K, Kataoka K. Block copolymer micelles in nanomedicine applications. Chem Rev. 2018;118:6844\u201392 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acs.chemrev.8b00199.","journal-title":"Chem Rev"},{"key":"818_CR101","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.reactfunctpolym.2010.10.009","volume":"71","author":"K Miyata","year":"2011","unstructured":"Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nano-scale drug delivery. React Funct Polym. 2011;71:227\u201334 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1381514810001835.","journal-title":"React Funct Polym"},{"key":"818_CR102","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","volume":"47","author":"K Kataoka","year":"2001","unstructured":"Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113\u201331 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X00001241.","journal-title":"Adv Drug Deliv Rev"},{"key":"818_CR103","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","volume":"248","author":"A Mandal","year":"2017","unstructured":"Mandal A, Bisht R, Rupenthal ID, Mitra AK. Polymeric micelles for ocular drug delivery: from structural frameworks to recent preclinical studies. J Control Release. 2017;248:96\u2013116 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300172.","journal-title":"J Control Release"},{"key":"818_CR104","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/1061186X.2014.997735","volume":"23","author":"KK Gill","year":"2015","unstructured":"Gill KK, Kaddoumi A, Nazzal S. PEG\u2013lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication. J Drug Target. 2015;23:222\u201331 Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/1061186X.2014.997735.","journal-title":"J Drug Target"},{"key":"818_CR105","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/nnm.10.10","volume":"5","author":"R Trivedi","year":"2010","unstructured":"Trivedi R, Kompella UB. Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine. 2010;5:485\u2013505 Available from: https:\/\/www.futuremedicine.com\/doi\/10.2217\/nnm.10.10.","journal-title":"Nanomedicine"},{"key":"818_CR106","doi-asserted-by":"crossref","unstructured":"Jhaveri AM, Torchilin VP. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol. 2014;5 Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2014.00077\/abstract.","DOI":"10.3389\/fphar.2014.00077"},{"key":"818_CR107","first-page":"265","volume":"13","author":"A Kumari","year":"2014","unstructured":"Kumari A, Singla R, Guliani A, Yadav SK. Nanoencapsulation for drug delivery. EXCLI J. 2014;13:265\u201386.","journal-title":"EXCLI J"},{"key":"818_CR108","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13233-010-0802-8","volume":"18","author":"YS Ahn","year":"2010","unstructured":"Ahn YS, Baik HJ, Lee BR, Lee ES, Oh KT, Lee DH, et al. Preparation of multifunctional polymeric micelles for antiviral treatment. Macromol Res. 2010;18:747\u201352 Available from: http:\/\/link.springer.com\/10.1007\/s13233-010-0802-8.","journal-title":"Macromol Res"},{"key":"818_CR109","unstructured":"Nagavarma BVN, Yadav HKS, Ayaz A, Vasudha LS, Shivakumar HG. Different techniques for preparation of polymeric nanoparticles-a review. Asian J Pharm Clin Res 2012;5(3):16-23."},{"key":"818_CR110","doi-asserted-by":"crossref","unstructured":"Verma G, Rajagopalan MD, Valluru R, Sridhar KA. Nanoparticles: a novel approach to target tumors. Nano- Microscale Drug Deliv Syst. Elsevier; 2017. p. 113\u201329. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323527279000078.","DOI":"10.1016\/B978-0-323-52727-9.00007-8"},{"key":"818_CR111","first-page":"84","volume":"5","author":"A Singh","year":"2010","unstructured":"Singh A, Garg G, Sharma PK. Nanospheres: a novel approach for targeted drug delivery system. Int J Pharm Sci Rev Res. 2010;5:84\u20138.","journal-title":"Int J Pharm Sci Rev Res"},{"key":"818_CR112","doi-asserted-by":"publisher","first-page":"22701","DOI":"10.1039\/C8NR05933K","volume":"10","author":"R Ferrari","year":"2018","unstructured":"Ferrari R, Sponchioni M, Morbidelli M, Moscatelli D. Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation. Nanoscale. 2018;10:22701\u201319 Available from: http:\/\/xlink.rsc.org\/?DOI=C8NR05933K.","journal-title":"Nanoscale"},{"key":"818_CR113","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/aps.2017.42","volume":"38","author":"C Qian","year":"2017","unstructured":"Qian C, Chen Y, Feng P, Xiao X, Dong M, Yu J, et al. Conjugated polymer nanomaterials for theranostics. Acta Pharmacol Sin. 2017;38:764\u201381 Available from: http:\/\/www.nature.com\/articles\/aps201742.","journal-title":"Acta Pharmacol Sin"},{"key":"818_CR114","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.2174\/0929867321666140826114135","volume":"21","author":"BJ Edagwa","year":"2014","unstructured":"Edagwa BJ, Zhou T, McMillan JM, Liu X-M, Gendelman HE. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies. Curr Med Chem. 2014;21:4186\u201398 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25174930.","journal-title":"Curr Med Chem"},{"key":"818_CR115","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.addr.2009.11.021","volume":"62","author":"S Gunaseelan","year":"2010","unstructured":"Gunaseelan S, Gunaseelan K, Deshmukh M, Zhang X, Sinko PJ. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev. 2010;62:518\u201331 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X09003627.","journal-title":"Adv Drug Deliv Rev"},{"key":"818_CR116","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"I Ekladious","year":"2019","unstructured":"Ekladious I, Colson YL, Grinstaff MW. Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov. 2019;18:273\u201394 Available from: http:\/\/www.nature.com\/articles\/s41573-018-0005-0.","journal-title":"Nat Rev Drug Discov"},{"key":"818_CR117","doi-asserted-by":"publisher","first-page":"24699","DOI":"10.1039\/C9RA04358F","volume":"9","author":"S Parveen","year":"2019","unstructured":"Parveen S, Arjmand F, Tabassum S. Clinical developments of antitumor polymer therapeutics. RSC Adv. 2019;9:24699\u2013721.","journal-title":"RSC Adv"},{"key":"818_CR118","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/cm2031569","volume":"24","author":"N Larson","year":"2012","unstructured":"Larson N, Ghandehari H. Polymeric conjugates for drug delivery. Chem Mater. 2012;24:840\u201353 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/cm2031569.","journal-title":"Chem Mater"},{"key":"818_CR119","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/jmv.24013","volume":"86","author":"X Chen","year":"2014","unstructured":"Chen X, Chen X, Chen W, Ma X, Huang J, Chen R. Extended peginterferon alfa-2a (Pegasys) therapy in Chinese patients with HBeAg-negative chronic hepatitis B. J Med Virol. 2014;86:1705\u201313 Available from: http:\/\/doi.wiley.com\/10.1002\/jmv.24013.","journal-title":"J Med Virol"},{"key":"818_CR120","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jconrel.2015.09.043","volume":"219","author":"J Li","year":"2015","unstructured":"Li J, Yu F, Chen Y, Oupick\u00fd D. Polymeric drugs: advances in the development of pharmacologically active polymers. J Control Release. 2015;219:369\u201382 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915301425.","journal-title":"J Control Release"},{"key":"818_CR121","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.bi.60.070191.002303","volume":"60","author":"L Kjell\u00e9n","year":"1991","unstructured":"Kjell\u00e9n L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem. 1991;60:443\u201375 Available from: http:\/\/www.annualreviews.org\/doi\/10.1146\/annurev.bi.60.070191.002303.","journal-title":"Annu Rev Biochem"},{"key":"818_CR122","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1128\/JVI.02622-06","volume":"81","author":"A Basu","year":"2007","unstructured":"Basu A, Kanda T, Beyene A, Saito K, Meyer K, Ray R. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol. 2007;81:3933\u201341 Available from: https:\/\/jvi.asm.org\/content\/81\/8\/3933.","journal-title":"J Virol"},{"key":"818_CR123","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.1039\/C4PY00624K","volume":"5","author":"AAA Smith","year":"2014","unstructured":"Smith AAA, Kryger MBL, Wohl BM, Ruiz-Sanchis P, Zuwala K, Tolstrup M, et al. Macromolecular (pro)drugs in antiviral research. Polym Chem. 2014;5:6407\u201325 Available from: http:\/\/xlink.rsc.org\/?DOI=C4PY00624K.","journal-title":"Polym Chem"},{"key":"818_CR124","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1021\/acsmacrolett.8b00179","volume":"7","author":"AHF Andersen","year":"2018","unstructured":"Andersen AHF, Riber CF, Zuwala K, Tolstrup M, Dagn\u00e6s-Hansen F, Denton PW, et al. Long-acting, potent delivery of combination antiretroviral therapy. ACS Macro Lett. 2018;7:587\u201391 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acsmacrolett.8b00179.","journal-title":"ACS Macro Lett"},{"key":"818_CR125","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S1369-7021(05)00746-7","volume":"8","author":"DA Tomalia","year":"2005","unstructured":"Tomalia DA. The dendritic state. Mater Today. 2005;8:34\u201346 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369702105007467.","journal-title":"Mater Today"},{"key":"818_CR126","first-page":"142","volume":"3","author":"S Tripathy","year":"2013","unstructured":"Tripathy S, Das MK. Dendrimers and their applications as novel drug delivery carriers. J Appl Pharm Sci. 2013;3:142\u20139 Available from: http:\/\/www.japsonline.com\/abstract.php?article_id=1064.","journal-title":"J Appl Pharm Sci"},{"key":"818_CR127","doi-asserted-by":"crossref","unstructured":"\u0160ebest\u00edk J, Reini\u0161 M, Je\u017eek J. Synthesis of dendrimers: convergent and divergent approaches. Biomed Appl Pept Glyco-Glycopeptide Dendrimers, Analog Dendrimeric Struct. Vienna: Springer Vienna; 2012. p. 55\u201381. Available from: http:\/\/link.springer.com\/10.1007\/978-3-7091-1206-9_6.","DOI":"10.1007\/978-3-7091-1206-9_6"},{"key":"818_CR128","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","volume":"12","author":"F Abedi-Gaballu","year":"2018","unstructured":"Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl Mater Today. 2018;12:177\u201390 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352940718301641.","journal-title":"Appl Mater Today"},{"key":"818_CR129","first-page":"211","volume":"7","author":"T Garg","year":"2011","unstructured":"Garg T, Singh O, Arora S, Murthy RSR. Dendrimer - a novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 2011;7:211\u201320.","journal-title":"Int J Pharm Sci Rev Res."},{"key":"818_CR130","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1128\/AAC.48.5.1614-1623.2004","volume":"48","author":"RD Kensinger","year":"2004","unstructured":"Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund C-L. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrob Agents Chemother. 2004;48:1614\u201323 Available from: https:\/\/aac.asm.org\/content\/48\/5\/1614.","journal-title":"Antimicrob Agents Chemother"},{"key":"818_CR131","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/joim.12280","volume":"276","author":"RM Kannan","year":"2014","unstructured":"Kannan RM, Nance E, Kannan S, Tomalia DA. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J Intern Med. 2014;276:579\u2013617 Available from: http:\/\/doi.wiley.com\/10.1111\/joim.12280.","journal-title":"J Intern Med"},{"key":"818_CR132","doi-asserted-by":"publisher","first-page":"e24095","DOI":"10.1371\/journal.pone.0024095","volume":"6","author":"CF Price","year":"2011","unstructured":"Price CF, Tyssen D, Sonza S, Davie A, Evans S, Lewis GR, et al. SPL7013 gel (VivaGel\u00ae) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. Goepfert PA, editor. PLoS One. 2011;6:e24095 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0024095.","journal-title":"PLoS One."},{"key":"818_CR133","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","volume":"90","author":"S Telwatte","year":"2011","unstructured":"Telwatte S, Moore K, Johnson A, Tyssen D, Sterjovski J, Aldunate M, et al. Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. Antiviral Res. 2011;90:195\u20139 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211002543.","journal-title":"Antiviral Res"},{"key":"818_CR134","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.nano.2015.03.008","volume":"11","author":"D Sep\u00falveda-Crespo","year":"2015","unstructured":"Sep\u00falveda-Crespo D, G\u00f3mez R, De La Mata FJ, Jim\u00e9nez JL, Mu\u00f1oz-Fern\u00e1ndez M\u00c1. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: recent trends and developments in HIV treatment\/therapy. Nanomed Nanotechnol Biol Med. 2015;11:1481\u201398 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000829.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"818_CR135","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nano.2016.08.018","volume":"13","author":"D Sep\u00falveda-Crespo","year":"2017","unstructured":"Sep\u00falveda-Crespo D, Jim\u00e9nez JL, G\u00f3mez R, De La Mata FJ, Majano PL, Mu\u00f1oz-Fern\u00e1ndez M\u00c1, et al. Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture. Nanomed Nanotechnol Biol Med. 2017;13:49\u201358 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963416301307.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"818_CR136","doi-asserted-by":"crossref","unstructured":"Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, et al. Prevention of influenza pneumonitis by sialic acid\u2013conjugated dendritic polymers. J Infect Dis [Internet. 2002;186:1222\u201330 Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1086\/344316.","DOI":"10.1086\/344316"},{"key":"818_CR137","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejmech.2015.05.026","volume":"98","author":"S Garc\u00eda-Gallego","year":"2015","unstructured":"Garc\u00eda-Gallego S, D\u00edaz L, Jim\u00e9nez JL, G\u00f3mez R, de la Mata FJ, Mu\u00f1oz-Fern\u00e1ndez M\u00c1. HIV-1 antiviral behavior of anionic PPI metallo-dendrimers with EDA core. Eur J Med Chem. 2015;98:139\u201348 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415300532.","journal-title":"Eur J Med Chem"},{"key":"818_CR138","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.eurpolymj.2017.03.012","volume":"90","author":"A Lancelot","year":"2017","unstructured":"Lancelot A, Claver\u00eda-Gimeno R, Vel\u00e1zquez-Campoy A, Abian O, Serrano JL, Sierra T. Nanostructures based on ammonium-terminated amphiphilic Janus dendrimers as camptothecin carriers with antiviral activity. Eur Polym J. 2017;90:136\u201349 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014305716314689.","journal-title":"Eur Polym J"},{"key":"818_CR139","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1039\/c0nj00116c","volume":"34","author":"A-M Caminade","year":"2010","unstructured":"Caminade A-M, Turrin C-O, Majoral J-P. Biological properties of phosphorus dendrimers. New J Chem. 2010;34:1512 Available from: http:\/\/xlink.rsc.org\/?DOI=c0nj00116c.","journal-title":"New J Chem"},{"key":"818_CR140","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.nano.2012.10.005","volume":"9","author":"SK Yandrapu","year":"2013","unstructured":"Yandrapu SK, Kanujia P, Chalasani KB, Mangamoori L, Kolapalli RV, Chauhan A. Development and optimization of thiolated dendrimer as a viable mucoadhesive excipient for the controlled drug delivery: an acyclovir model formulation. Nanomed Nanotechnol Biol Med. 2013;9:514\u201322 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963412006028.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"818_CR141","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.antiviral.2016.12.010","volume":"139","author":"B Mart\u00ednez-Gualda","year":"2017","unstructured":"Mart\u00ednez-Gualda B, Sun L, Rivero-Buceta E, Flores A, Quesada E, Balzarini J, et al. Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid. Antivir Res. 2017;139:32\u201340 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216306222.","journal-title":"Antivir Res"},{"key":"818_CR142","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/039139880502801114","volume":"28","author":"C Mayer","year":"2005","unstructured":"Mayer C. Nanocapsules as drug delivery systems. Int J Artif Organs. 2005;28:1163\u201371.","journal-title":"Int J Artif Organs"},{"key":"818_CR143","doi-asserted-by":"crossref","unstructured":"Parboosing R, Maguire GEM, Govender P, Kruger HG, Albert I, Central L, et al. Nanotechnology and the treatment of HIV infection. Viruses. 2012;4(4):488\u2013520.","DOI":"10.3390\/v4040488"},{"key":"818_CR144","first-page":"84","volume":"5","author":"A Singh","year":"2010","unstructured":"Singh A, Garg G, Sharma PK. Review article. Nanospheres: a novel approach for targeted drug delivery system. Int J Pharm Sci Rev Res. 2010;5:84\u20138.","journal-title":"Int J Pharm Sci Rev Res."},{"key":"818_CR145","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/pharmaceutics10020046","volume":"10","author":"M Donalisio","year":"2018","unstructured":"Donalisio M, Leone F, Civra A, Spagnolo R, Ozer O, Lembo D, et al. Acyclovir-loaded chitosan nanospheres from nano-emulsion templating for the topical treatment of herpesviruses infections. Pharmaceutics. 2018;10:46 Available from: http:\/\/www.mdpi.com\/1999-4923\/10\/2\/46.","journal-title":"Pharmaceutics"},{"key":"818_CR146","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nrd1576","volume":"3","author":"ME Davis","year":"2004","unstructured":"Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov. 2004;3:1023\u201335.","journal-title":"Nat Rev Drug Discov"},{"key":"818_CR147","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1590\/S1984-82502011000400003","volume":"47","author":"JCD Miranda","year":"2011","unstructured":"Miranda JCD, Martins TEA, Veiga F, Ferraz HG. Cyclodextrins and ternary complexes: technology to improve solubility of poorly soluble drugs. Braz J Pharm Sci. 2011;47:665\u201381.","journal-title":"Braz J Pharm Sci"},{"key":"818_CR148","doi-asserted-by":"publisher","unstructured":"Shelley H, Babu RJ. Role of cyclodextrins in nanoparticle based drug delivery systems. J Pharm Sci. American Pharmacists Association; 2018. https:\/\/doi.org\/10.1016\/j.xphs.2018.03.021.","DOI":"10.1016\/j.xphs.2018.03.021"},{"key":"818_CR149","doi-asserted-by":"crossref","unstructured":"Voncina B, Vivo V. Cyclodextrins in Textile Finishing. Eco-friendly text dye finish. InTech; 2013. Available from: http:\/\/www.intechopen.com\/books\/eco-friendly-textile-dyeing-and-finishing\/cyclodextrins-in-textile-finishing.","DOI":"10.5772\/53777"},{"key":"818_CR150","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/nano4030741","volume":"4","author":"L Zerkoune","year":"2014","unstructured":"Zerkoune L, Angelova A, Lesieur S. Nano-assemblies of modified cyclodextrins and their complexes with guest molecules: incorporation in nanostructured membranes and amphiphile nanoarchitectonics design. Nanomaterials. 2014;4:741\u201365 Available from: http:\/\/www.mdpi.com\/2079-4991\/4\/3\/741.","journal-title":"Nanomaterials"},{"key":"818_CR151","doi-asserted-by":"crossref","unstructured":"Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res. 2006.","DOI":"10.1007\/s11095-006-0284-8"},{"key":"818_CR152","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s00018-019-03138-w","volume":"76","author":"LCP Vilas Boas","year":"2019","unstructured":"Vilas Boas LCP, Campos ML, Berlanda RLA, de Carvalho Neves N, Franco OL. Antiviral peptides as promising therapeutic drugs. Cell Mol Life Sci. 2019;76:3525\u201342 Available from: http:\/\/link.springer.com\/10.1007\/s00018-019-03138-w.","journal-title":"Cell Mol Life Sci"},{"key":"818_CR153","doi-asserted-by":"crossref","unstructured":"Lee W, Lee S-H, Ahn D-G, Cho H, Sung M-H, Han SH, et al. The antiviral activity of poly-\u03b3-glutamic acid, a polypeptide secreted by Bacillus sp., through induction of CD14-dependent type I interferon responses. Biomaterials [Internet. 2013;34:9700\u20138 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213010302.","DOI":"10.1016\/j.biomaterials.2013.08.067"},{"key":"818_CR154","doi-asserted-by":"crossref","unstructured":"Ding X, Zhang X, Chong H, Zhu Y, Wei H, Wu X, et al. Enfuvirtide (T20)-based lipopeptide is a potent HIV-1 cell fusion Inhibitor: implications for viral entry and inhibition. Kirchhoff F, editor. J Virol. 2017;91. Available from: https:\/\/jvi.asm.org\/lookup\/doi\/10.1128\/JVI.00831-17.","DOI":"10.1128\/JVI.00831-17"},{"key":"818_CR155","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1021\/bi400166b","volume":"52","author":"A Emileh","year":"2013","unstructured":"Emileh A, Tuzer F, Yeh H, Umashankara M, Moreira DRM, LaLonde JM, et al. A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption. Biochemistry. 2013;52:2245\u201361 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/bi400166b.","journal-title":"Biochemistry"},{"key":"818_CR156","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3762\/bjnano.10.104","volume":"10","author":"ZK Alghrair","year":"2019","unstructured":"Alghrair ZK, Fernig DG, Ebrahimi B. Enhanced inhibition of influenza virus infection by peptide\u2013noble-metal nanoparticle conjugates. Beilstein J Nanotechnol. 2019;10:1038\u201347 Available from: https:\/\/www.beilstein-journals.org\/bjnano\/articles\/10\/104.","journal-title":"Beilstein J Nanotechnol"},{"key":"818_CR157","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/c5010003","volume":"5","author":"G Rahman","year":"2019","unstructured":"Rahman G, Najaf Z, Mehmood A, Bilal S, Mian SA, Ali G. An overview of the recent progress in the synthesis and applications of carbon nanotubes. C\u2014J Carbon Res. 2019;5:3.","journal-title":"C\u2014J Carbon Res"},{"key":"818_CR158","doi-asserted-by":"crossref","unstructured":"Kaur J, Gill GS, Jeet K. Applications of carbon nanotubes in drug delivery. Charact Biol Nanomater Drug Deliv. Elsevier; 2019. p. 113\u201335. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128140314000052.","DOI":"10.1016\/B978-0-12-814031-4.00005-2"},{"key":"818_CR159","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3390\/ma3053092","volume":"3","author":"A Szab\u00f3","year":"2010","unstructured":"Szab\u00f3 A, Perri C, Csat\u00f3 A, Giordano G, Vuono D, Nagy JB. Synthesis methods of carbon nanotubes and related materials. Materials (Basel). 2010;3:3092\u2013140 Available from: http:\/\/www.mdpi.com\/1996-1944\/3\/5\/3092.","journal-title":"Materials (Basel)"},{"key":"818_CR160","doi-asserted-by":"crossref","unstructured":"Shao W, Arghya P, Yiyong M, Rodes L, Prakash S. Carbon nanotubes for use in medicine: potentials and limitations. Synth Appl carbon Nanotub their compos: InTech; 2013. Available from: http:\/\/www.intechopen.com\/books\/syntheses-and-applications-of-carbon-nanotubes-and-their-composites\/carbon-nanotubes-for-use-in-medicine-potentials-and-limitations.","DOI":"10.5772\/51785"},{"key":"818_CR161","doi-asserted-by":"crossref","unstructured":"Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N Carbon nanotubes: properties , synthesis , purification, and medical applications. Nanoscale Res Lett. 2014;9(1):393.","DOI":"10.1186\/1556-276X-9-393"},{"key":"818_CR162","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1872211308666140124095745","volume":"8","author":"R Kumar","year":"2014","unstructured":"Kumar R, Dhanawat M, Kumar S, Singh B, Pandit J, Sinha V. Carbon nanotubes: a potential concept for drug delivery applications. Recent Pat Drug Deliv Formul. 2014;8:12\u201326 Available from: http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1872-2113&volume=8&issue=1&spage=12.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"818_CR163","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12951-017-0259-4","volume":"15","author":"AF Versiani","year":"2017","unstructured":"Versiani AF, Astigarraga RG, Rocha ESO, Barboza APM, Kroon EG, Rachid MA, et al. Multi-walled carbon nanotubes functionalized with recombinant dengue virus 3 envelope proteins induce significant and specific immune responses in mice. J Nanobiotechnol. 2017;15:26 Available from: http:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-017-0259-4.","journal-title":"J Nanobiotechnol"},{"key":"818_CR164","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2217\/fvl-2017-0086","volume":"12","author":"LM Andrade","year":"2017","unstructured":"Andrade LM, Cox L, Versiani AF, da Fonseca FG. A growing world of small things: a brief review on the nanostructured vaccines. Future Virol. 2017;12:767\u201379 Available from: https:\/\/www.futuremedicine.com\/doi\/10.2217\/fvl-2017-0086.","journal-title":"Future Virol"},{"key":"818_CR165","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.chembiol.2003.09.011","volume":"10","author":"D Pantarotto","year":"2003","unstructured":"Pantarotto D, Partidos CD, Hoebeke J, Brown F, Kramer E, Briand J-P, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol. 2003;10:961\u20136 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107455210300214X.","journal-title":"Chem Biol"},{"key":"818_CR166","doi-asserted-by":"crossref","unstructured":"Casimir D, Alghamdi H, Ahmed YI, Garcia-Sanchez R, Misra P. Raman spectroscopy of graphene, graphite and graphene nanoplatelets. 2D Mater. IntechOpen; 2019. Available from: https:\/\/www.intechopen.com\/books\/2d-materials\/raman-spectroscopy-of-graphene-graphite-and-graphene-nanoplatelets.","DOI":"10.5772\/intechopen.84527"},{"key":"818_CR167","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/nano9081180","volume":"9","author":"E Aliyev","year":"2019","unstructured":"Aliyev E, Filiz V, Khan MM, Lee YJ, Abetz C, Abetz V. Structural characterization of graphene oxide: surface functional groups and fractionated oxidative debris. Nanomaterials. 2019;9:1180 Available from: https:\/\/www.mdpi.com\/2079-4991\/9\/8\/1180.","journal-title":"Nanomaterials"},{"key":"818_CR168","doi-asserted-by":"publisher","first-page":"15804","DOI":"10.1039\/C9NR05273A","volume":"11","author":"IS Donskyi","year":"2019","unstructured":"Donskyi IS, Azab W, Cuellar-Camacho JL, Guday G, Lippitz A, Unger WES, et al. Functionalized nanographene sheets with high antiviral activity through synergistic electrostatic and hydrophobic interactions. Nanoscale. 2019;11:15804\u20139 Available from: http:\/\/xlink.rsc.org\/?DOI=C9NR05273A.","journal-title":"Nanoscale"},{"key":"818_CR169","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/nano8020125","volume":"8","author":"K Lategan","year":"2018","unstructured":"Lategan K, Alghadi H, Bayati M, de Cortalezzi M, Pool E. Effects of graphene oxide nanoparticles on the immune system biomarkers produced by RAW 264.7 and human whole blood cell cultures. Nanomaterials. 2018;8:125 Available from: http:\/\/www.mdpi.com\/2079-4991\/8\/2\/125.","journal-title":"Nanomaterials"},{"key":"818_CR170","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1039\/C8CP00797G","volume":"20","author":"AJP Neto","year":"2018","unstructured":"Neto AJP, Fileti EE. Elucidating the amphiphilic character of graphene oxide. Phys Chem Chem Phys. 2018;20:9507\u201315.","journal-title":"Phys Chem Chem Phys"},{"key":"818_CR171","doi-asserted-by":"crossref","unstructured":"Dideikin AT, Vul\u2019 AY. Graphene oxide and derivatives: the place in graphene family. Front Phys. 2019;6 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fphy.2018.00149\/full.","DOI":"10.3389\/fphy.2018.00149"},{"key":"818_CR172","doi-asserted-by":"publisher","first-page":"125129","DOI":"10.1063\/1.5063474","volume":"8","author":"R Pokhrel","year":"2018","unstructured":"Pokhrel R, Sompornpisut P, Chapagain P, Olson B, Gerstman B, Pandey RB. Domain rearrangement and denaturation in Ebola virus protein VP40. AIP Adv. 2018;8:125129 Available from: http:\/\/aip.scitation.org\/doi\/10.1063\/1.5063474.","journal-title":"AIP Adv"},{"key":"818_CR173","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1021\/acs.bioconjchem.7b00030","volume":"28","author":"AR Deokar","year":"2017","unstructured":"Deokar AR, Nagvenkar AP, Kalt I, Shani L, Yeshurun Y, Gedanken A, et al. Graphene-based \u201chot plate\u201d for the capture and destruction of the herpes simplex virus type 1. Bioconjug Chem. 2017;28:1115\u201322.","journal-title":"Bioconjug Chem"},{"key":"818_CR174","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.mattod.2017.03.017","volume":"20","author":"S Goodarzi","year":"2017","unstructured":"Goodarzi S, Da Ros T, Conde J, Sefat F, Mozafari M. Fullerene: biomedical engineers get to revisit an old friend. Mater Today. 2017;20:460\u201380 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369702116301808.","journal-title":"Mater Today"},{"key":"818_CR175","first-page":"639","volume":"2","author":"R Bakry","year":"2007","unstructured":"Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, et al. Medicinal applications of fullerenes. Int J Nanomed. 2007;2:639\u201349 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18203430.","journal-title":"Int J Nanomed"},{"key":"818_CR176","doi-asserted-by":"crossref","unstructured":"Bondavalli P. Carbon and its new allotropes: fullerene, carbon nanotubes, and graphene. Graphene Relat Nanomater. Elsevier; 2018. p. 1\u201340. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323481014000011.","DOI":"10.1016\/B978-0-323-48101-4.00001-1"},{"key":"818_CR177","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1128\/AAC.00341-16","volume":"60","author":"ZS Martinez","year":"2016","unstructured":"Martinez ZS, Castro E, Seong C-S, Cer\u00f3n MR, Echegoyen L, Llano M. Fullerene derivatives strongly inhibit HIV-1 replication by affecting virus maturation without impairing protease activity. Antimicrob Agents Chemother. 2016;60:5731\u201341 Available from: https:\/\/aac.asm.org\/content\/60\/10\/5731.","journal-title":"Antimicrob Agents Chemother"},{"key":"818_CR178","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1016\/j.bmcl.2003.09.016","volume":"13","author":"S Bosi","year":"2003","unstructured":"Bosi S, Da Ros T, Spalluto G, Balzarini J, Prato M. Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60]fullerene derivatives. Bioorg Med Chem Lett. 2003;13:4437\u201340 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X03009703.","journal-title":"Bioorg Med Chem Lett"},{"key":"818_CR179","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.bmcl.2004.12.030","volume":"15","author":"T Mashino","year":"2005","unstructured":"Mashino T, Shimotohno K, Ikegami N, Nishikawa D, Okuda K, Takahashi K, et al. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Bioorg Med Chem Lett. 2005;15:1107\u20139 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X04014908.","journal-title":"Bioorg Med Chem Lett"},{"key":"818_CR180","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1016\/j.bmcl.2005.05.069","volume":"15","author":"S Marchesan","year":"2005","unstructured":"Marchesan S, Da Ros T, Spalluto G, Balzarini J, Prato M. Anti-HIV properties of cationic fullerene derivatives. Bioorg Med Chem Lett. 2005;15:3615\u20138 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X05006244.","journal-title":"Bioorg Med Chem Lett"},{"key":"818_CR181","doi-asserted-by":"publisher","first-page":"e66337","DOI":"10.1371\/journal.pone.0066337","volume":"8","author":"M Shoji","year":"2013","unstructured":"Shoji M, Takahashi E, Hatakeyama D, Iwai Y, Morita Y, Shirayama R, et al. Anti-influenza activity of C60 fullerene derivatives. Digard P, editor. PLoS One. 2013;8:e66337 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0066337.","journal-title":"PLoS One"},{"key":"818_CR182","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.bmcl.2014.04.032","volume":"24","author":"S Tollas","year":"2014","unstructured":"Tollas S, Bereczki I, Borb\u00e1s A, Batta G, Vanderlinden E, Naesens L, et al. Synthesis of a cluster-forming sialylthio-d-galactose fullerene conjugate and evaluation of its interaction with influenza virus hemagglutinin and neuraminidase. Bioorganic Med Chem Lett. Elsevier Ltd. 2014;24:2420\u20133. https:\/\/doi.org\/10.1016\/j.bmcl.2014.04.032.","journal-title":"Bioorganic Med Chem Lett"},{"key":"818_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbon.2014.11.007","volume":"3977464","author":"D Iannazzo","year":"2014","unstructured":"Iannazzo D, Pistone A, Galvagno S, Ferro S, De Luca L, Maria A, et al. Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes. Carbon N Y. Elsevier Ltd. 2014;3977464:1\u201314. https:\/\/doi.org\/10.1016\/j.carbon.2014.11.007.","journal-title":"Carbon N Y"},{"key":"818_CR184","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1039\/C7NR06520E","volume":"9","author":"XX Yang","year":"2017","unstructured":"Yang XX, Li CM, Li YF, Wang J, Huang CZ. Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection. Nanoscale. 2017;9:16086\u201392 Available from: http:\/\/xlink.rsc.org\/?DOI=C7NR06520E.","journal-title":"Nanoscale"},{"key":"818_CR185","doi-asserted-by":"publisher","first-page":"21571","DOI":"10.1021\/acsami.5b06876","volume":"7","author":"S Ye","year":"2015","unstructured":"Ye S, Shao K, Li Z, Guo N, Zuo Y, Li Q, et al. Antiviral activity of graphene oxide: how sharp edged structure and charge matter. ACS Appl Mater Interfaces. 2015;7:21571\u20139 Available from: http:\/\/pubs.acs.org\/doi\/10.1021\/acsami.5b06876.","journal-title":"ACS Appl Mater Interfaces"},{"key":"818_CR186","doi-asserted-by":"crossref","unstructured":"Iannazzo D, Pistone A, Ferro S, Luca L De, Romeo R, Buemi MR, et al. Graphene quantum dots based systems as HIV Inhibitors. Bioconjug Chem. 2018;29(9):3084-3093.","DOI":"10.1021\/acs.bioconjchem.8b00448"},{"key":"818_CR187","doi-asserted-by":"crossref","unstructured":"Illescas BM, Rojo J, Delgado R, Mart N. Multivalent glycosylated nanostructures to inhibit Ebola virus infection. J Am Chem Soc. 2017:6018\u201325.","DOI":"10.1021\/jacs.7b01683"},{"key":"818_CR188","doi-asserted-by":"publisher","first-page":"e1800293","DOI":"10.1002\/cbdv.201800293","volume":"15","author":"II Voronov","year":"2018","unstructured":"Voronov II, Martynenko VM, Chernyak AV, Balzarini J, Schols D, Troshin PA. Synthesis and antiviral activity of water-soluble polycarboxylic derivatives of [60]fullerene loaded with 3,4-dichlorophenyl units. Chem Biodivers. 2018;15:e1800293 Available from: http:\/\/doi.wiley.com\/10.1002\/cbdv.201800293.","journal-title":"Chem Biodivers"},{"key":"818_CR189","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1021\/acsami.6b01681","volume":"8","author":"A Barras","year":"2016","unstructured":"Barras A, Pagneux Q, Sane F, Wang Q, Boukherroub R, Hober D, et al. High efficiency of functional carbon nanodots as entry inhibitors of herpes simplex virus type 1. ACS Appl Mater Interfaces. 2016;8:9004\u201313.","journal-title":"ACS Appl Mater Interfaces"},{"key":"818_CR190","first-page":"2113","volume":"6","author":"P Malik","year":"2013","unstructured":"Malik P, Gulati N, Malik RK, Nagaich U. Carbon nanotubes, quantum dots and dendrimers as potential nanodevices for nanotechnology drug delivery systems. Int J Pharm Sci NanotechInt J Pharm Sci Nanotech. 2013;6:2113\u201324.","journal-title":"Int J Pharm Sci NanotechInt J Pharm Sci Nanotech"},{"key":"818_CR191","unstructured":"Klimov VI, Hollingsworth JA, Crooker SA, Kim H. Los Alamos National Security LLC 2007. Multifunctional nanocrystals. 2007. p. U.S. Patent 7, 261, 940."},{"key":"818_CR192","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.2147\/IJN.S138624","volume":"12","author":"C Matea","year":"2017","unstructured":"Matea C, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, et al. Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomedicine. 2017;12:5421\u201331 Available from: https:\/\/www.dovepress.com\/quantum-dots-in-imaging-drug-delivery-and-sensor-applications-peer-reviewed-article-IJN.","journal-title":"Int J Nanomedicine"},{"key":"818_CR193","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jlumin.2018.09.015","volume":"205","author":"VG Reshma","year":"2019","unstructured":"Reshma VG, Mohanan PV. Quantum dots: applications and safety consequences. J Lumin. 2019;205:287\u201398 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022231318313334.","journal-title":"J Lumin"},{"key":"818_CR194","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102 Available from: http:\/\/nanoscalereslett.springeropen.com\/articles\/10.1186\/1556-276X-8-102.","journal-title":"Nanoscale Res Lett"},{"key":"818_CR195","doi-asserted-by":"crossref","unstructured":"Yong K, Wang Y, Roy I, Rui H, Swihart MT, Law W, et al. Preparation of quantum dot \/ drug nanoparticle formulations for traceable targeted delivery and therapy. Theranostics. 2012;2(7):681.","DOI":"10.7150\/thno.3692"},{"key":"818_CR196","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nano.2016.08.016","volume":"13","author":"T Yadavalli","year":"2017","unstructured":"Yadavalli T, Shukla D. Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections. Nanomed Nanotechnol Biol Med. 2017;13:219\u201330 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963416301289.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"818_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4270454","volume":"2019","author":"HO Demchenko","year":"2019","unstructured":"Demchenko HO, Rusinchuk NM. Evaluation of the efficiency of interparticle interactions in nanosystems. J Nanotechnol. 2019;2019:1\u20138 Available from: https:\/\/www.hindawi.com\/journals\/jnt\/2019\/4270454\/.","journal-title":"J Nanotechnol"},{"key":"818_CR198","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","volume":"65","author":"JL Markman","year":"2013","unstructured":"Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev. 2013;65:1866\u201379. https:\/\/doi.org\/10.1016\/j.addr.2013.09.019.","journal-title":"Adv Drug Deliv Rev"},{"key":"818_CR199","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.2147\/IJN.S140772","volume":"12","author":"J Guo","year":"2017","unstructured":"Guo J, Rahme K, He Y, Li L-L, Holmes J, O\u2019Driscoll C. Gold nanoparticles enlighten the future of cancer theranostics. Int J Nanomedicine. 2017;12:6131\u201352 Available from: https:\/\/www.dovepress.com\/gold-nanoparticles-enlighten-the-future-of-cancer-theranostics-peer-reviewed-article-IJN.","journal-title":"Int J Nanomedicine"},{"key":"818_CR200","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jare.2010.02.002","volume":"1","author":"X Huang","year":"2010","unstructured":"Huang X, El-Sayed MA. Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res. 2010;1:13\u201328 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123210000056.","journal-title":"J Adv Res"},{"key":"818_CR201","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4155\/fmc.15.140","volume":"7","author":"J Bayo","year":"2015","unstructured":"Bayo J, MP D, Martinez E. Medicinal chemistry. Future Med Chem. 2015;7:450\u201361.","journal-title":"Future Med Chem"},{"key":"818_CR202","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1099\/vir.0.066084-0","volume":"95","author":"AM Paul","year":"2014","unstructured":"Paul AM, Shi Y, Acharya D, Douglas JR, Cooley A, Anderson JF, et al. Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro. J Gen Virol. 2014;95:1712\u201322 Available from: http:\/\/jgv.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.066084-0.","journal-title":"J Gen Virol"},{"key":"818_CR203","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nmat5053","volume":"17","author":"V Cagno","year":"2018","unstructured":"Cagno V, Andreozzi P, D\u2019Alicarnasso M, Silva PJ, Mueller M, Galloux M, et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater. 2018;17:195\u2013203.","journal-title":"Nat Mater"},{"key":"818_CR204","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.msec.2018.04.005","volume":"89","author":"A Halder","year":"2018","unstructured":"Halder A, Das S, Ojha D, Chattopadhyay D, Mukherjee A. Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections. Mater Sci Eng C Mater Biol Appl. 2018;89:413\u201321 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29752114.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"818_CR205","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/molecules21070836","volume":"21","author":"G Rudramurthy","year":"2016","unstructured":"Rudramurthy G, Swamy M, Sinniah U, Ghasemzadeh A. Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules. 2016;21:836 Available from: http:\/\/www.mdpi.com\/1420-3049\/21\/7\/836.","journal-title":"Molecules"},{"key":"818_CR206","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.3390\/ma6062295","volume":"6","author":"B Reidy","year":"2013","unstructured":"Reidy B, Haase A, Luch A, Dawson K, Lynch I. Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications. Materials (Basel). 2013;6:2295\u2013350 Available from: http:\/\/www.mdpi.com\/1996-1944\/6\/6\/2295.","journal-title":"Materials (Basel)"},{"key":"818_CR207","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/2228-5326-2-32","volume":"2","author":"S Prabhu","year":"2012","unstructured":"Prabhu S, Poulose EK. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett. 2012;2:32 Available from: http:\/\/link.springer.com\/10.1186\/2228-5326-2-32.","journal-title":"Int Nano Lett"},{"key":"818_CR208","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.3390\/molecules16108894","volume":"16","author":"S Galdiero","year":"2011","unstructured":"Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16:8894\u2013918 Available from: http:\/\/www.mdpi.com\/1420-3049\/16\/10\/8894.","journal-title":"Molecules"},{"key":"818_CR209","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1021\/bc900215b","volume":"20","author":"D Baram-Pinto","year":"2009","unstructured":"Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem. 2009;20:1497\u2013502 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/bc900215b.","journal-title":"Bioconjug Chem"},{"key":"818_CR210","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jviromet.2011.09.003","volume":"178","author":"D Xiang","year":"2011","unstructured":"Xiang D, Chen Q, Pang L, Zheng C. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods. 2011;178:137\u201342 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093411003788.","journal-title":"J Virol Methods"},{"key":"818_CR211","doi-asserted-by":"publisher","first-page":"24385","DOI":"10.1021\/acsami.6b06613","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Lin Z, Zhao M, Xu T, Wang C, Hua L, et al. Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways. ACS Appl Mater Interfaces. 2016;8:24385\u201393 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acsami.6b06613.","journal-title":"ACS Appl Mater Interfaces"},{"key":"818_CR212","doi-asserted-by":"crossref","unstructured":"Wang M, Marepally SK, Vemula PK, Xu C. Inorganic nanoparticles for transdermal drug delivery and topical application. Nanosci Dermatol. Elsevier; 2016. p. 57\u201372. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128029268000057.","DOI":"10.1016\/B978-0-12-802926-8.00005-7"},{"key":"818_CR213","unstructured":"Zaid K. Alghrair DGF and Ebrahimi B. Enhanced inhibition of influenza virus infection by peptide-noble metal nanoparticle conjugates. BioRXiv. 2018;15:2017\u20139. Available from: https:\/\/www.uam.es\/gruposinv\/meva\/publicacionesjesus\/capitulos_espanyol_jesus\/2005_motivacionparaelaprendizajePerspectivaalumnos.pdf, https:\/\/www.researchgate.net\/profile\/Juan_Aparicio7\/publication\/253571379_Los_estudios_sobre_el_cambio_conceptual_."},{"key":"818_CR214","doi-asserted-by":"publisher","first-page":"14051","DOI":"10.3390\/molecules200814051","volume":"20","author":"S Szunerits","year":"2015","unstructured":"Szunerits S, Barras A, Khanal M, Pagneux Q, Boukherroub R. Nanostructures for the inhibition of viral infections. Molecules. 2015;20:14051\u201381 Available from: http:\/\/www.mdpi.com\/1420-3049\/20\/8\/14051.","journal-title":"Molecules"},{"key":"818_CR215","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.4049\/jimmunol.1502373","volume":"196","author":"TE Antoine","year":"2016","unstructured":"Antoine TE, Hadigal SR, Yakoub AM, Mishra YK, Bhattacharya P, Haddad C, et al. Intravaginal zinc oxide tetrapod nanoparticles as novel immunoprotective agents against genital herpes. J Immunol. 2016;196:4566\u201375 Available from: http:\/\/www.jimmunol.org\/lookup\/doi\/10.4049\/jimmunol.1502373.","journal-title":"J Immunol"},{"key":"818_CR216","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/nn800596w","volume":"3","author":"PV AshaRani","year":"2009","unstructured":"AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279\u201390 Available from: http:\/\/pubs.acs.org\/doi\/10.1021\/nn800596w.","journal-title":"ACS Nano"},{"key":"818_CR217","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1021\/es900754q","volume":"43","author":"K Kawata","year":"2009","unstructured":"Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009;43:6046\u201351 Available from: http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/es900754q.","journal-title":"Environ Sci Technol"},{"key":"818_CR218","doi-asserted-by":"crossref","unstructured":"Lin Z, Li Y, Guo M, Xiao M, Wang C, Zhao M, et al. Inhibition of H1N1 influenza virus by selenium nanoparticles loaded with zanamivir through p38 and JNK signaling pathways. RSC Adv. Royal Society of Chemistry; 2017;7:35290\u20136. Available from: http:\/\/xlink.rsc.org\/?DOI=C7RA06477B.","DOI":"10.1039\/C7RA06477B"},{"key":"818_CR219","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2147\/IJN.S155994","volume":"13","author":"Y Li","year":"2018","unstructured":"Li Y, Lin Z, Guo M, Zhao M, Xia Y, Wang C, et al. Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways. Int J Nanomedicine. 2018;13:2005\u201316.","journal-title":"Int J Nanomedicine"},{"key":"818_CR220","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jviromet.2015.06.010","volume":"222","author":"X Hang","year":"2015","unstructured":"Hang X, Peng H, Song H, Qi Z, Miao X, Xu W. Antiviral activity of cuprous oxide nanoparticles against hepatitis C virus in vitro. J Virol Methods. 2015;222:150\u20137 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093415002268.","journal-title":"J Virol Methods"},{"key":"818_CR221","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/157016212803901383","volume":"10","author":"S Vijayakumar","year":"2012","unstructured":"Vijayakumar S, Ganesan S. Gold nanoparticles as an HIV entry inhibitor. Curr HIV Res. 2012;10:643\u20136 Available from: http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1570-162X&volume=10&issue=8&spage=643.","journal-title":"Curr HIV Res"},{"key":"818_CR222","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/nano1010031","volume":"1","author":"P Tiwari","year":"2011","unstructured":"Tiwari P, Vig K, Dennis V, Singh S. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials. 2011;1:31\u201363 Available from: http:\/\/www.mdpi.com\/2079-4991\/1\/1\/31.","journal-title":"Nanomaterials"},{"key":"818_CR223","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13404-017-0213-0","volume":"50","author":"S Borker","year":"2017","unstructured":"Borker S, Patole M, Moghe A, Pokharkar V. Engineering of pectin-reduced gold nanoparticles for targeted delivery of an antiviral drug to macrophages: in vitro and in vivo assessment. Gold Bull. 2017;50:235\u201346 Available from: http:\/\/link.springer.com\/10.1007\/s13404-017-0213-0.","journal-title":"Gold Bull"},{"key":"818_CR224","first-page":"143","volume":"31","author":"R Kesarkar","year":"2015","unstructured":"Kesarkar R, Yeole M, Dalvi B, Sharon M, Chowdhary A. Gold nanosphere intermediate for drug conjugation. Int J Pharm Sci Rev. 2015;31:143\u20136.","journal-title":"Int J Pharm Sci Rev"},{"key":"818_CR225","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pestbp.2017.11.004","volume":"144","author":"H Ga\u2019al","year":"2018","unstructured":"Ga\u2019al H, Fouad H, Tian J, Hu Y, Abbas G, Mo J. Synthesis, characterization and efficacy of silver nanoparticles against Aedes albopictus larvae and pupae. Pestic Biochem Physiol. 2018;144:49\u201356 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0048357517301232.","journal-title":"Pestic Biochem Physiol"},{"key":"818_CR226","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1556-276X-8-93","volume":"8","author":"Y Mori","year":"2013","unstructured":"Mori Y, Ono T, Miyahira Y, Nguyen VQ, Matsui T, Ishihara M. Antiviral activity of silver nanoparticle\/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett. 2013;8:93 Available from: http:\/\/nanoscalereslett.springeropen.com\/articles\/10.1186\/1556-276X-8-93.","journal-title":"Nanoscale Res Lett"},{"key":"818_CR227","doi-asserted-by":"crossref","unstructured":"Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid\u2013polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomed. 2019;14:1937\u201352 Available from: https:\/\/www.dovepress.com\/lipid-polymer-hybrid-nanoparticles-as-a-next-generation-drug-delivery%2D%2Dpeer-reviewed-article-IJN.","DOI":"10.2147\/IJN.S198353"},{"key":"818_CR228","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mimet.2019.03.017","volume":"160","author":"V Dave","year":"2019","unstructured":"Dave V, Tak K, Sohgaura A, Gupta A, Sadhu V, Reddy KR. Lipid-polymer hybrid nanoparticles: synthesis strategies and biomedical applications. J Microbiol Methods. 2019;160:130\u201342 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701219300533.","journal-title":"J Microbiol Methods"},{"key":"818_CR229","doi-asserted-by":"publisher","unstructured":"Date T, Nimbalkar V, Kamat J, Mittal A, Mahato RI, Chitkara D. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics Tushar. J Control Release. Elsevier B.V; 2017; Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.016.","DOI":"10.1016\/j.jconrel.2017.12.016"},{"key":"818_CR230","first-page":"21","volume":"3","author":"R Article","year":"2019","unstructured":"Article R, Kumari L, Al HA, Sakure K, Badwaik HR. Recent advancements in the lipid polymer hybrid nanoparticles for drug delivery: an overview. Acta Sci Pharm Sci. 2019;3:21\u20138.","journal-title":"Acta Sci Pharm Sci"},{"key":"818_CR231","unstructured":"Joshy KS, Snigdha S, Thomas A, George A, Kalarikkal N, Pothen LA, et al. Nanotechnology in HIV \/ AIDS: lipids and lipid hybrid systems-novel delivery approaches on antiviral drugs. JSM Nanotechnol Nanomed. 2018;6."},{"key":"818_CR232","doi-asserted-by":"publisher","unstructured":"Joshy KS, Snigdha S, Kalarikkal N, Pothen LA, Thomas S. Gelatin modified lipid nanoparticles for anti retroviral drug delivery. Chem. Phys. Lipids. Elsevier Ireland Ltd; 2017. https:\/\/doi.org\/10.1016\/j.chemphyslip.2017.07.002.","DOI":"10.1016\/j.chemphyslip.2017.07.002"},{"key":"818_CR233","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ijbiomac.2017.05.094","volume":"103","author":"KS Joshy","year":"2017","unstructured":"Joshy KS, George A, Jose J, Kalarikkal N, Pothen LA, Thomas S. Novel dendritic structure of alginate hybrid nanoparticles for effective anti-viral drug delivery. Int J Biol Macromol. Elsevier B.V. 2017;103:1265\u201375. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.05.094.","journal-title":"Int J Biol Macromol"},{"key":"818_CR234","doi-asserted-by":"crossref","unstructured":"Joshy KS, George A, Snigdha S, Joseph B, Kalarikkal N, Pothen LA, et al. Novel core-shell dextran hybrid nanosystem for anti-viral drug delivery. Mater Sci Eng C. Elsevier B.V; 2018;#pagerange#. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493117336962.","DOI":"10.1016\/j.msec.2018.08.015"},{"key":"818_CR235","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.chemphyslip.2017.11.003","volume":"210","author":"KS Joshy","year":"2018","unstructured":"Joshy KS, Snigdha S, Anne G, Nandakumar K, Laly AP, Sabu T. Poly (vinyl pyrrolidone)-lipid based hybrid nanoparticles for anti viral drug delivery. Chem Phys Lipids. 2018;210:82\u20139.","journal-title":"Chem Phys Lipids"},{"key":"818_CR236","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.apsb.2017.12.002","volume":"8","author":"K Jin","year":"2018","unstructured":"Jin K, Luo Z, Zhang B, Pang Z. Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B. 2018;8:23\u201333 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383517303672.","journal-title":"Acta Pharm Sin B"},{"key":"818_CR237","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/pharmaceutics11100534","volume":"11","author":"V Vijayan","year":"2019","unstructured":"Vijayan V, Mohapatra A, Uthaman S, Park IK. Recent advances in nanovaccines using biomimetic immunomodulatory materials. Pharmaceutics. 2019;11:534 Available from: https:\/\/www.mdpi.com\/1999-4923\/11\/10\/534.","journal-title":"Pharmaceutics"},{"key":"818_CR238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.aivir.2016.09.002","volume":"97","author":"B Schwarz","year":"2017","unstructured":"Schwarz B, Uchida M, Douglas T. Biomedical and catalytic opportunities of virus-like particles in nanotechnology. Adv Virus Res. 2017;97:1\u201360 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065352716300501.","journal-title":"Adv Virus Res"},{"key":"818_CR239","first-page":"166","volume":"5","author":"A Abdoli","year":"2013","unstructured":"Abdoli A, Soleimanjahi H, Kheiri MT, Jamali A, Sohani H, Abdoli M, et al. Reconstruction of H3N2 influenza virus based virosome in-vitro. Iran J Microbiol. 2013;5:166\u201371 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23825736.","journal-title":"Iran J Microbiol"},{"key":"818_CR240","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","volume":"147","author":"A Parodi","year":"2017","unstructured":"Parodi A, Molinaro R, Sushnitha M, Evangelopoulos M, Martinez JO, Arrighetti N, et al. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. Biomaterials. Elsevier Ltd. 2017;147:155\u201368. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.020.","journal-title":"Biomaterials"},{"key":"818_CR241","doi-asserted-by":"crossref","unstructured":"Yang G, Chen S, Zhang J. Bioinspired and biomimetic nanotherapies for the treatment of infectious diseases. Front Pharmacol. 2019;10 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00751\/full.","DOI":"10.3389\/fphar.2019.00751"},{"key":"818_CR242","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo M, Wei C-J, Yassine HM, McTamney PM, Boyington JC, Whittle JRR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102\u20136 Available from: http:\/\/www.nature.com\/articles\/nature12202.","journal-title":"Nature"},{"key":"818_CR243","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","volume":"176","author":"J Marcandalli","year":"2019","unstructured":"Marcandalli J, Fiala B, Ols S, Perotti M, de van der Schueren W, Snijder J, et al. Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus. Cell. 2019;176:1420\u20131431.e17 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867419301096.","journal-title":"Cell"},{"key":"818_CR244","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1039\/C5CS00798D","volume":"45","author":"M Karimi","year":"2016","unstructured":"Karimi M, Ghasemi A, Sahandi Zangabad P, Rahighi R, Moosavi Basri SM, Mirshekari H, et al. Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems. Chem Soc Rev. 2016;45:1457\u2013501 Available from: http:\/\/xlink.rsc.org\/?DOI=C5CS00798D.","journal-title":"Chem Soc Rev"},{"key":"818_CR245","doi-asserted-by":"publisher","first-page":"10556","DOI":"10.1021\/la202123e","volume":"27","author":"C Clawson","year":"2011","unstructured":"Clawson C, Ton L, Aryal S, Fu V, Esener S, Zhang L. Synthesis and characterization of lipid\u2013polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) shedding. Langmuir. 2011;27:10556\u201361 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/la202123e.","journal-title":"Langmuir"},{"key":"818_CR246","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jconrel.2015.08.050","volume":"219","author":"J Du","year":"2015","unstructured":"Du J, Lane LA, Nie S. Stimuli-responsive nanoparticles for targeting the tumor microenvironment. J Control Release. 2015;219:205\u201314 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915300936.","journal-title":"J Control Release"},{"key":"818_CR247","doi-asserted-by":"crossref","unstructured":"Hallan SS, Kaur P, Kaur V, Mishra N, Vaidya B. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Artif Cells Nanomed Biotechnol. 2014:1\u201316.","DOI":"10.3109\/21691401.2014.951721"},{"key":"818_CR248","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/molecules21081002","volume":"21","author":"P Mahlumba","year":"2016","unstructured":"Mahlumba P, Choonara Y, Kumar P, du Toit L, Pillay V. Stimuli-responsive polymeric systems for controlled protein and peptide delivery: future implications for ocular delivery. Molecules. 2016;21:1002 Available from: http:\/\/www.mdpi.com\/1420-3049\/21\/8\/1002.","journal-title":"Molecules"},{"key":"818_CR249","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s10856-012-4664-9","volume":"23","author":"N Li","year":"2012","unstructured":"Li N, Yu M, Deng L, Yang J, Dong A. Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery. J Mater Sci Mater Med. 2012;23:1913\u20139 Available from: http:\/\/link.springer.com\/10.1007\/s10856-012-4664-9.","journal-title":"J Mater Sci Mater Med"},{"key":"818_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/389640","volume":"2011","author":"P Shao","year":"2011","unstructured":"Shao P, Wang B, Wang Y, Li J, Zhang Y. The application of thermosensitive nanocarriers in controlled drug delivery. J Nanomater. 2011;2011:1\u201312 Available from: http:\/\/www.hindawi.com\/journals\/jnm\/2011\/389640\/.","journal-title":"J Nanomater"},{"key":"818_CR251","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/21691401.2019.1596935","volume":"47","author":"W Tian","year":"2019","unstructured":"Tian W, Han S, Huang X, Han M, Cao J, Liang Y, et al. LDH hybrid thermosensitive hydrogel for intravaginal delivery of anti-HIV drugs. Artif Cells Nanomed Biotechnol. 2019;47:1234\u201340 Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21691401.2019.1596935.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"818_CR252","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/pharmaceutics10020039","volume":"10","author":"A Dalpiaz","year":"2018","unstructured":"Dalpiaz A, Pavan B. Nose-to-brain delivery of antiviral drugs: a way to overcome their active efflux? Pharmaceutics. 2018;10:39 Available from: http:\/\/www.mdpi.com\/1999-4923\/10\/2\/39.","journal-title":"Pharmaceutics"},{"key":"818_CR253","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2010.03.038","volume":"666","author":"AS de Dios","year":"2010","unstructured":"de Dios AS, D\u00edaz-Garc\u00eda ME. Multifunctional nanoparticles: analytical prospects. Anal Chim Acta. 2010;666:1\u201322 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267010003211.","journal-title":"Anal Chim Acta"},{"key":"818_CR254","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.tibtech.2008.04.005","volume":"26","author":"N Sanvicens","year":"2008","unstructured":"Sanvicens N, Marco MP. Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol. 2008;26:425\u201333.","journal-title":"Trends Biotechnol"},{"key":"818_CR255","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13204-016-0540-0","volume":"7","author":"NA Alkubaisi","year":"2017","unstructured":"Alkubaisi NA, Aref NMA. Dispersed gold nanoparticles potentially ruin gold barley yellow dwarf virus and eliminate virus infectivity hazards. Appl Nanosci. 2017;7:31\u201340 Available from: http:\/\/link.springer.com\/10.1007\/s13204-016-0540-0.","journal-title":"Appl Nanosci"},{"key":"818_CR256","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ijbiomac.2018.05.113","volume":"116","author":"D Liu","year":"2018","unstructured":"Liu D, Lian Y, Fang Q, Liu L, Zhang J, Li J. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride. Int J Biol Macromol. 2018;116:1026\u201336 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813018306032.","journal-title":"Int J Biol Macromol"},{"key":"818_CR257","doi-asserted-by":"publisher","first-page":"9522","DOI":"10.1021\/nn302538y","volume":"6","author":"M-Y Lee","year":"2012","unstructured":"Lee M-Y, Yang J-A, Jung HS, Beack S, Choi JE, Hur W, et al. Hyaluronic acid\u2013gold nanoparticle\/interferon \u03b1 complex for targeted treatment of hepatitis C virus infection. ACS Nano. 2012;6:9522\u201331 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/nn302538y.","journal-title":"ACS Nano"},{"key":"818_CR258","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4155\/tde.11.156","volume":"3","author":"Y Liu","year":"2012","unstructured":"Liu Y, Tan J, Thomas A, Ou-Yang D, Muzykantov VR. The shape of things to come: importance of design in nanotechnology for drug delivery. Ther Deliv. 2012;3:181\u201394 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22834196.","journal-title":"Ther Deliv"},{"key":"818_CR259","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/nano9101365","volume":"9","author":"C Aur\u00eda-Soro","year":"2019","unstructured":"Aur\u00eda-Soro C, Nesma T, Juanes-Velasco P, Landeira-Vi\u00f1uela A, Fidalgo-Gomez H, Acebes-Fernandez V, et al. Interactions of nanoparticles and biosystems: microenvironment of nanoparticles and biomolecules in nanomedicine. Nanomaterials. 2019;9:1365 Available from: https:\/\/www.mdpi.com\/2079-4991\/9\/10\/1365.","journal-title":"Nanomaterials"},{"key":"818_CR260","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neubiorev.2017.10.011","volume":"84","author":"LB Samuelsson","year":"2018","unstructured":"Samuelsson LB, Bovbjerg DH, Roecklein KA, Hall MH. Sleep and circadian disruption and incident breast cancer risk: an evidence-based and theoretical review. Neurosci Biobehav Rev. 2018;84:35\u201348. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.10.011.","journal-title":"Neurosci Biobehav Rev"},{"key":"818_CR261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3702518","volume":"2019","author":"D Lombardo","year":"2019","unstructured":"Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019:1\u201326 Available from: https:\/\/www.hindawi.com\/journals\/jnm\/2019\/3702518\/.","journal-title":"J Nanomater"},{"key":"818_CR262","doi-asserted-by":"crossref","unstructured":"Mendel, J., 1999. Dispersions and coatings. Nanostructure Sci Technol. 1999;35\u201347 Springer, Dordrecht.","DOI":"10.1007\/978-94-015-9185-0_3"},{"key":"818_CR263","doi-asserted-by":"crossref","unstructured":"Law W, Reynolds JL, Yong K. Anti-HIV-1 nanotherapeutics: promises and challenges for the future. Int J Nanomedicine. 2012;7:5301\u201314.","DOI":"10.2147\/IJN.S25871"},{"key":"818_CR264","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.biomaterials.2011.01.021","volume":"32","author":"K Xiao","year":"2011","unstructured":"Xiao K, Li Y, Luo J, Lee JS, Xiao W, Gonik AM, et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 2011;32:3435\u201346 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961211000342.","journal-title":"Biomaterials"},{"key":"818_CR265","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1517\/17425255.2012.637916","volume":"8","author":"A Sharma","year":"2012","unstructured":"Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol. 2012;8:47\u201369 Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17425255.2012.637916.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"818_CR266","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/10611860802475688","volume":"16","author":"CD Kaur","year":"2008","unstructured":"Kaur CD, Nahar M, Jain NK. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target. 2008;16:798\u2013805.","journal-title":"J Drug Target"},{"key":"818_CR267","doi-asserted-by":"crossref","unstructured":"Al-Halifa S, Gauthier L, Arpin D, Bourgault S, Archambault D. Nanoparticle-based vaccines against respiratory viruses. Front Immunol. 2019;10 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00022\/full.","DOI":"10.3389\/fimmu.2019.00022"},{"key":"818_CR268","first-page":"8","volume":"s8","author":"JCS Ther","year":"2015","unstructured":"Ther JCS, Agarwal M. Role of nanovaccine in immunotherapy. J Cell Sci Ther. 2015;s8:8\u201311 Available from: https:\/\/www.omicsonline.org\/open-access\/role-of-nanovaccine-in-immunotherapy-2157-7013-S8-003.php?aid=61096.","journal-title":"J Cell Sci Ther"},{"key":"818_CR269","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1016\/j.molimm.2008.06.027","volume":"45","author":"SY Chu","year":"2008","unstructured":"Chu SY, Vostiar I, Karki S, Moore GL, Lazar GA, Pong E, et al. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies. Mol Immunol. 2008;45:3926\u201333 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18691763.","journal-title":"Mol Immunol"},{"key":"818_CR270","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.nano.2018.03.007","volume":"14","author":"C Wang","year":"2018","unstructured":"Wang C, Zhu W, Luo Y, Wang B-Z. Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity. Nanomed Nanotechnol Biol Med. 2018;14:1349\u201360 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963418300698.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"818_CR271","doi-asserted-by":"crossref","unstructured":"Marques Neto LM, Kipnis A, Junqueira-Kipnis AP. Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development. Front Immunol. 2017;8 Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00239\/full.","DOI":"10.3389\/fimmu.2017.00239"},{"key":"818_CR272","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng L, Mohan T, Chang TZ, Gonzalez GX, Wang Y, Kwon Y-M, et al. Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nat Commun. 2018;9:359 Available from: http:\/\/www.nature.com\/articles\/s41467-017-02725-4.","journal-title":"Nat Commun"},{"key":"818_CR273","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/jmv.24253","volume":"87","author":"Q Liu","year":"2015","unstructured":"Liu Q, Zheng X, Zhang C, Shao X, Zhang X, Zhang Q, et al. Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration. J Med Virol. 2015;87:1807\u201315 Available from: http:\/\/doi.wiley.com\/10.1002\/jmv.24253.","journal-title":"J Med Virol"},{"key":"818_CR274","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.vaccine.2018.02.072","volume":"36","author":"M Dabaghian","year":"2018","unstructured":"Dabaghian M, Latifi AM, Tebianian M, NajmiNejad H, Ebrahimi SM. Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: preparation and immunogenicity in a mouse model. Vaccine. 2018;36:2886\u201395 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302597.","journal-title":"Vaccine"},{"key":"818_CR275","doi-asserted-by":"crossref","unstructured":"Francica JR, Lynn GM, Laga R, Joyce MG, Ruckwardt TJ, Morabito KM, et al. Thermoresponsive polymer nanoparticles co-deliver RSV F trimers with a TLR-7\/8 adjuvant. Bioconjug Chem. 2016;27:2372\u20132385. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acs.bioconjchem.6b00370.","DOI":"10.1021\/acs.bioconjchem.6b00370"},{"key":"818_CR276","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11095-008-9760-7","volume":"26","author":"BD Ulery","year":"2009","unstructured":"Ulery BD, Phanse Y, Sinha A, Wannemuehler MJ, Narasimhan B, Bellaire BH. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres. Pharm Res. 2009;26:683\u201390 Available from: http:\/\/link.springer.com\/10.1007\/s11095-008-9760-7.","journal-title":"Pharm Res"},{"key":"818_CR277","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.nano.2016.08.006","volume":"13","author":"P-L Herv\u00e9","year":"2017","unstructured":"Herv\u00e9 P-L, Deloizy C, Descamps D, Rameix-Welti M-A, Fix J, McLellan JS, et al. RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine. Nanomed Nanotechnol Biol Med. 2017;13:411\u201320 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963416301149.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"818_CR278","doi-asserted-by":"crossref","unstructured":"Zhang S, Huang S, Lu L, Song X, Li P, Wang F. Curdlan sulfate\u2013O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination. Int J Nanomedicine. 2018;13:2377\u201394 Available from: https:\/\/www.dovepress.com\/curdlan-sulfate-o-linked-quaternized-chitosan-nanoparticles-potential%2D%2Dpeer-reviewed-article-IJN.","DOI":"10.2147\/IJN.S158536"},{"key":"818_CR279","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/srep00198","volume":"1","author":"BD Ulery","year":"2011","unstructured":"Ulery BD, Petersen LK, Phanse Y, Kong CS, Broderick SR, Kumar D, et al. Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. Sci Rep. 2011;1:198 Available from: http:\/\/www.nature.com\/articles\/srep00198.","journal-title":"Sci Rep"},{"key":"818_CR280","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/ind.2006.2.14","volume":"2","author":"GM Bohlmann","year":"2006","unstructured":"Bohlmann GM. Process economic considerations for production of ethanol from biomass feedstocks. Ind Biotechnol. 2006;2:14\u201320 Available from: http:\/\/www.liebertpub.com\/doi\/10.1089\/ind.2006.2.14.","journal-title":"Ind Biotechnol"},{"key":"818_CR281","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","volume":"14","author":"J L\u00f3pez-Sagaseta","year":"2016","unstructured":"L\u00f3pez-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J. 2016;14:58\u201368 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S200103701530009X.","journal-title":"Comput Struct Biotechnol J"},{"key":"818_CR282","doi-asserted-by":"publisher","first-page":"e62500","DOI":"10.1371\/journal.pone.0062500","volume":"8","author":"S Vicente","year":"2013","unstructured":"Vicente S, Diaz-Freitas B, Peleteiro M, Sanchez A, Pascual DW, Gonzalez-Fernandez A, et al. A polymer\/oil based nanovaccine as a single-dose immunization approach. Boyaka PN, editor. PLoS One. 2013;8:e62500 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0062500.","journal-title":"PLoS One"},{"key":"818_CR283","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1021\/acsnano.8b07662","volume":"13","author":"TG Dacoba","year":"2019","unstructured":"Dacoba TG, Omange RW, Li H, Crecente-Campo J, Luo M, Alonso MJ. Polysaccharide nanoparticles can efficiently modulate the immune response against an HIV peptide antigen. ACS Nano. 2019;13:4947\u201359 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acsnano.8b07662.","journal-title":"ACS Nano"},{"key":"818_CR284","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.7150\/ijbs.45134","volume":"16","author":"Y Yi","year":"2020","unstructured":"Yi Y, Lagniton PNP, Ye S, Li E, Xu R-H. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16:1753\u201366 Available from: http:\/\/www.ijbs.com\/v16p1753.htm.","journal-title":"Int J Biol Sci"},{"key":"818_CR285","doi-asserted-by":"crossref","unstructured":"Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020;12 Available from: https:\/\/www.cureus.com\/articles\/29589-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-an-update.","DOI":"10.7759\/cureus.7423"},{"key":"818_CR286","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1128\/JVI.00483-06","volume":"80","author":"D Su","year":"2006","unstructured":"Su D, Lou Z, Sun F, Zhai Y, Yang H, Zhang R, et al. Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10. J Virol. 2006;80:7902\u20138 Available from: https:\/\/jvi.asm.org\/content\/80\/16\/7902.","journal-title":"J Virol"},{"key":"818_CR287","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virol.2008.06.038","volume":"379","author":"SG Fang","year":"2008","unstructured":"Fang SG, Shen H, Wang J, Tay FPL, Liu DX. Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11\/12 of coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells. Virology. 2008;379:175\u201380 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682208004340.","journal-title":"Virology"},{"key":"818_CR288","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.tim.2004.08.008","volume":"12","author":"H Hofmann","year":"2004","unstructured":"Hofmann H, P\u00f6hlmann S. Cellular entry of the SARS coronavirus. Trends Microbiol. 2004;12:466\u201372 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X04001878.","journal-title":"Trends Microbiol"},{"key":"818_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. 2015;1282:1\u201323 Available from: http:\/\/link.springer.com\/10.1007\/978-1-4939-2438-7_1.","journal-title":"Coronaviruses"},{"key":"818_CR290","doi-asserted-by":"crossref","unstructured":"Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2020:1\u201310 Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07391102.2020.1758788.","DOI":"10.1080\/07391102.2020.1758788"},{"key":"818_CR291","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"C-C Lai","year":"2020","unstructured":"Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300674.","journal-title":"Int J Antimicrob Agents"},{"key":"818_CR292","unstructured":"An Overview of Nanotechnology Patents Focusing on Coronaviruses | STATNANO. [cited 2020 Jun 5]. Available from: https:\/\/statnano.com\/news\/67513\/An-Overview-of-Nanotechnology-Patents-Focusing-on-Coronaviruses."},{"key":"818_CR293","doi-asserted-by":"crossref","unstructured":"Dormont F, Brusini R, Cailleau C, Reynaud F, Peramo A, Gendron A, et al. Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation. Sci Adv. 2020:eaaz5466 Available from: https:\/\/advances.sciencemag.org\/lookup\/doi\/10.1126\/sciadv.aaz5466.","DOI":"10.1126\/sciadv.aaz5466"},{"key":"818_CR294","unstructured":"Arcturus reports positive preclinical data for its COVID-19 vaccine candidate | Arcturus Therapeutics, Inc.. [cited 2020 Jun 5]. Available from: https:\/\/ir.arcturusrx.com\/news-releases\/news-release-details\/arcturus-reports-positive-preclinical-data-its-covid-19-vaccine."},{"key":"818_CR295","unstructured":"Alnylam\u00ae Pharmaceuticals. [cited 2020 Jun 5]. Available from: https:\/\/www.alnylam.com\/."},{"key":"818_CR296","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/1381612823666171109112307","volume":"24","author":"SS Sohrab","year":"2018","unstructured":"Sohrab SS, El-Kafrawy SA, Mirza Z, Kamal MA, Azhar EI. Design and delivery of therapeutic siRNAs: application to MERS-coronavirus. Curr Pharm Des. 2018;24:62\u201377 Available from: http:\/\/www.eurekaselect.com\/156958\/article.","journal-title":"Curr Pharm Des"},{"key":"818_CR297","unstructured":"University of Waterloo developing DNA-based COVID-19 vaccine | Waterloo Stories | University of Waterloo. [cited 2020 Jun 5]. Available from: https:\/\/uwaterloo.ca\/stories\/news\/university-waterloo-developing-dna-based-covid-19-vaccine."},{"key":"818_CR298","unstructured":"China leverages nanotechnology to deactivate the novel coronavirus | STATNANO. [cited 2020 Jun 5]. Available from: https:\/\/statnano.com\/news\/67544\/China-Leverages-Nanotechnology-to-Deactivate-the-Novel-Coronavirus."},{"key":"818_CR299","unstructured":"Novavax awarded funding from CEPI for COVID-19 vaccine development | Novavax Inc. - IR Site. [cited 2020 Jun 5]. Available from: https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-awarded-funding-cepi-covid-19-vaccine-development."},{"key":"818_CR300","unstructured":"Forest business working to prevent spread of coronavirus, products sent internationally | WSET. [cited 2020 Jun 5]. Available from: https:\/\/wset.com\/news\/local\/forest-business-working-to-prevent-spread-of-coronavirus-products-sent-internationally."},{"key":"818_CR301","unstructured":"Iran leverages nanotechnology to launch West Asia\u2019s largest face mask production plant | STATNANO. [cited 2020 Jun 5]. Available from: https:\/\/statnano.com\/news\/67581\/Iran-Leverages-Nanotechnology-to-Launch-West-Asia\u2019s-Largest-Face-Mask-Production-Plant."},{"key":"818_CR302","unstructured":"COVID-19 report & analysis \u2014 World Nano Foundation. [cited 2020 Jun 5]. Available from: https:\/\/www.worldnanofoundation.com\/covid-19-report-analysis."},{"key":"818_CR303","unstructured":"Producing iron oxide nanoparticles for 150,000 COVID-19 tests per week. [cited 2020 Jun 6]. Available from: https:\/\/www.nanowerk.com\/nanotechnology-news2\/newsid=54893.php."},{"key":"818_CR304","unstructured":"Nanotechnology in battle against coronavirus | STATNANO. [cited 2020 Jun 2]. Available from: https:\/\/statnano.com\/nanotechnology-in-battle-against-coronavirus."},{"key":"818_CR305","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres M d P, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16:71 Available from: https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-018-0392-8.","journal-title":"J Nanobiotechnol"},{"key":"818_CR306","unstructured":"Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. P T. 2017;42:742\u201355. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29234213."},{"key":"818_CR307","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s11671-018-2457-x","volume":"13","author":"A Sukhanova","year":"2018","unstructured":"Sukhanova A, Bozrova S, Sokolov P, Berestovoy M, Karaulov A, Nabiev I. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res Lett. 2018;13:44 Available from: https:\/\/nanoscalereslett.springeropen.com\/articles\/10.1186\/s11671-018-2457-x.","journal-title":"Nanoscale Res Lett"},{"key":"818_CR308","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jfda.2014.01.005","volume":"22","author":"PP Fu","year":"2014","unstructured":"Fu PP, Xia Q, Hwang H-M, Ray PC, Yu H. Mechanisms of nanotoxicity: generation of reactive oxygen species. J Food Drug Anal. 2014;22:64\u201375 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1021949814000064.","journal-title":"J Food Drug Anal"},{"key":"818_CR309","doi-asserted-by":"crossref","unstructured":"Ahadian S, Radisic M. Nanotoxicity. Nanobiomaterials Sci Dev Eval. Elsevier; 2017. p. 233\u201348. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780081009635000124.","DOI":"10.1016\/B978-0-08-100963-5.00012-4"},{"key":"818_CR310","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/08860220701860914","volume":"30","author":"A Sereemaspun","year":"2008","unstructured":"Sereemaspun A, Rojanathanes R, Wiwanitkit V. Effect of gold nanoparticle on renal cell: an implication for exposure risk. Ren Fail. 2008;30:323\u20135.","journal-title":"Ren Fail"},{"key":"818_CR311","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.etap.2015.09.003","volume":"40","author":"JJ Antony","year":"2015","unstructured":"Antony JJ, Sivalingam PCB. Toxicological effects of silver nanoparticles. Environ Toxicol Pharmacol. 2015;40:729\u201332.","journal-title":"Environ Toxicol Pharmacol"},{"key":"818_CR312","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.1038\/srep11170","volume":"5","author":"T Yoisungnern","year":"2015","unstructured":"Yoisungnern T, Choi Y-J, Han JW, Kang M-H, Das JGS. Internalization of silver nanoparticles into mouse spermatozoa results in poor fertilization and compromised embryo development. Sci Rep. 2015;5:11170.","journal-title":"Sci Rep"},{"key":"818_CR313","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.fct.2014.12.019","volume":"77","author":"S Gaillet","year":"2015","unstructured":"Gaillet S. RJ-MF 2015. Silver nanoparticles: their potential toxic effects after oral exposure and underlying mechanisms-a review. Chem Toxicol. 2015;77:58\u201363.","journal-title":"Chem Toxicol"},{"key":"818_CR314","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/tx800064j","volume":"21","author":"HL Karlsson","year":"2008","unstructured":"Karlsson HL, Cronholm P, Gustafsson JML. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol. 2008;21:1726\u201332.","journal-title":"Chem Res Toxicol"},{"key":"818_CR315","doi-asserted-by":"publisher","first-page":"1871e7","DOI":"10.1021\/tx800179f","volume":"21","author":"CY Jin","year":"2008","unstructured":"Jin CY, Zhu BS, Wang XF, et al. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol. 2008;21:1871e7.","journal-title":"Chem Res Toxicol"},{"key":"818_CR316","first-page":"3880e8","volume":"13","author":"C-C Wang","year":"2013","unstructured":"Wang C-C, Wang S, Xia Q, et al. Phototoxicity of zinc oxide nanoparticles in HaCaT keratinocytes e generation of oxidative DNA damage during UVA and visible light irradiation. J Nanosci Nanotechnol. 2013;13:3880e8.","journal-title":"J Nanosci Nanotechnol"},{"key":"818_CR317","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.ajpath.2011.02.040","volume":"178","author":"FA Murphy","year":"2011","unstructured":"Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol. 2011;178:2587\u2013600 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011002744.","journal-title":"Am J Pathol"},{"key":"818_CR318","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.tiv.2011.05.027","volume":"25","author":"D Guti\u00e9rrez-Praena","year":"2011","unstructured":"Guti\u00e9rrez-Praena D, Pichardo S, S\u00e1nchez E, Grilo A, Came\u00e1n AM, Jos A. Influence of carboxylic acid functionalization on the cytotoxic effects induced by single wall carbon nanotubes on human endothelial cells (HUVEC). Toxicol in Vitro. 2011;25:1883\u20138 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233311001639.","journal-title":"Toxicol in Vitro"},{"key":"818_CR319","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1021\/nn305567s","volume":"7","author":"R Li","year":"2013","unstructured":"Li R, Wang X, Ji Z, Sun B, Zhang H, Chang CH, et al. Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. ACS Nano. 2013;7:2352\u201368 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/nn305567s.","journal-title":"ACS Nano"},{"key":"818_CR320","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1021\/tx400385x","volume":"27","author":"AB Seabra","year":"2014","unstructured":"Seabra AB, Paula AJ, de Lima R, Alves OL, Dur\u00e1n N. Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol. 2014;27:159\u201368 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/tx400385x.","journal-title":"Chem Res Toxicol"},{"key":"818_CR321","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s11051-014-2379-1","volume":"16","author":"N Voigt","year":"2014","unstructured":"Voigt N, Henrich-Noack P, Kockentiedt S, Hintz W, Tomas J, Sabel BA. Toxicity of polymeric nanoparticles in vivo and in vitro. J Nanopart Res. 2014;16:2379 Available from: http:\/\/link.springer.com\/10.1007\/s11051-014-2379-1.","journal-title":"J Nanopart Res"},{"key":"818_CR322","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1039\/C8NR02278J","volume":"10","author":"S Mourdikoudis","year":"2018","unstructured":"Mourdikoudis S, Pallares RM, Thanh NTK. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale. 2018;10:12871\u2013934 Available from: http:\/\/xlink.rsc.org\/?DOI=C8NR02278J.","journal-title":"Nanoscale."},{"key":"818_CR323","doi-asserted-by":"crossref","unstructured":"Soares S, Sousa J, Pais A, Vitorino C. Nanomedicine: principles, properties, and regulatory issues. Front Chem. 2018;6 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2018.00360\/full.","DOI":"10.3389\/fchem.2018.00360"},{"key":"818_CR324","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/2049-632X.12136","volume":"71","author":"N Shafagati","year":"2014","unstructured":"Shafagati N, Patanarut A, Luchini A, Lundberg L, Bailey C, Petricoin E, et al. The use of nanotrap particles for biodefense and emerging infectious disease diagnostics. Pathog Dis. 2014;71:164\u201376 Available from: https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/2049-632X.12136.","journal-title":"Pathog Dis"},{"key":"818_CR325","doi-asserted-by":"publisher","first-page":"e96778","DOI":"10.1371\/journal.pone.0096778","volume":"9","author":"E Jaworski","year":"2014","unstructured":"Jaworski E, Saifuddin M, Sampey G, Shafagati N, Van Duyne R, Iordanskiy S, et al. The use of nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells. Jacobson S, editor. PLoS One. 2014;9:e96778 Available from: http:\/\/dx.plos.org\/10.1371\/journal.pone.0096778.","journal-title":"PLoS One"},{"key":"818_CR326","doi-asserted-by":"publisher","first-page":"e0128215","DOI":"10.1371\/journal.pone.0128215","volume":"10","author":"N Shafagati","year":"2015","unstructured":"Shafagati N, Lundberg L, Baer A, Patanarut A, Fite K, Lepene B, et al. The use of nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein. Ikegami T, editor. PLoS One. 2015;10:e0128215 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0128215.","journal-title":"PLoS One"},{"key":"818_CR327","doi-asserted-by":"publisher","first-page":"e2296","DOI":"10.1371\/journal.pntd.0002296","volume":"7","author":"N Shafagati","year":"2013","unstructured":"Shafagati N, Narayanan A, Baer A, Fite K, Pinkham C, Bailey C, et al. The use of nanotrap particles as a sample enrichment method to enhance the detection of Rift Valley fever virus. Peters CJ, editor. PLoS Negl Trop Dis. 2013;7:e2296 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002296.","journal-title":"PLoS Negl Trop Dis"},{"key":"818_CR328","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/21505594.2016.1185585","volume":"7","author":"N Shafagati","year":"2016","unstructured":"Shafagati N, Fite K, Patanarut A, Baer A, Pinkham C, An S, et al. Enhanced detection of respiratory pathogens with nanotrap particles. Virulence. 2016;7:756\u201369.","journal-title":"Virulence."},{"key":"818_CR329","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.vaccine.2019.04.078","volume":"37","author":"H Cheng","year":"2019","unstructured":"Cheng H, Chen J, Cai Z, Du L, Hou J, Qiao X, et al. Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus. Vaccine. 2019;37:3205\u201313 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305663.","journal-title":"Vaccine"},{"key":"818_CR330","doi-asserted-by":"crossref","unstructured":"Akhrymuk I, Lin S-C, Sun M, Patnaik A, Lehman C, Altamura L, et al. Magnetic nanotrap particles preserve the stability of Venezuelan equine encephalitis virus in blood for laboratory detection. Front Vet Sci. 2020;6 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2019.00509\/full.","DOI":"10.3389\/fvets.2019.00509"},{"key":"818_CR331","doi-asserted-by":"publisher","first-page":"e0227058","DOI":"10.1371\/journal.pone.0227058","volume":"15","author":"S-C Lin","year":"2020","unstructured":"Lin S-C, Carey BD, Callahan V, Lee J-H, Bracci N, Patnaik A, et al. Use of nanotrap particles for the capture and enrichment of Zika, chikungunya and dengue viruses in urine. Roques P, editor. PLoS One. 2020;15:e0227058 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0227058.","journal-title":"PLoS One"},{"key":"818_CR332","doi-asserted-by":"crossref","unstructured":"Mavroidis C, Ferreira A, editors. Nanorobotics: current approaches and techniques: Springer; 2013.","DOI":"10.1007\/978-1-4614-2119-1"},{"key":"818_CR333","first-page":"42","volume":"2","author":"A Manjunath","year":"2014","unstructured":"Manjunath A, Kishore V. The promising future in medicine: nanorobots. Biomed Sci Eng. 2014;2:42\u20137.","journal-title":"Biomed Sci Eng"},{"key":"818_CR334","doi-asserted-by":"crossref","unstructured":"Nistor MT, Rusu AG. Nanorobots with applications in medicine. Polym Nanomater Nanotherapeutics. Elsevier; 2019. p. 123\u201349. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128139325000030.","DOI":"10.1016\/B978-0-12-813932-5.00003-0"},{"key":"818_CR335","unstructured":"Ravi Bandakkanavar. Anti-HIV using nanorobots - Krazytech. [cited 2018 Aug 11]. Available from: https:\/\/krazytech.com\/technical-papers\/anti-hiv-using-nano-robots."},{"key":"818_CR336","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4155\/tde.15.92","volume":"7","author":"R Cavalli","year":"2016","unstructured":"Cavalli R, Soster M, Argenziano M. Nanobubbles: a promising efficienft tool for therapeutic delivery. Ther Deliv. 2016;7:117\u201338 Available from: http:\/\/www.future-science.com\/doi\/10.4155\/tde.15.92.","journal-title":"Ther Deliv"},{"key":"818_CR337","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.actbio.2020.03.034","volume":"108","author":"L Song","year":"2020","unstructured":"Song L, Wang G, Hou X, Kala S, Qiu Z, Wong KF, et al. Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer. Acta Biomater. 2020;108:313\u201325 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706120301756.","journal-title":"Acta Biomater"},{"key":"818_CR338","doi-asserted-by":"publisher","first-page":"15567","DOI":"10.1021\/acsomega.9b01924","volume":"4","author":"A Prabhakar","year":"2019","unstructured":"Prabhakar A, Banerjee R. Nanobubble liposome complexes for diagnostic imaging and ultrasound-triggered drug delivery in cancers: a theranostic approach. ACS Omega. 2019;4:15567\u201380 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acsomega.9b01924.","journal-title":"ACS Omega"},{"key":"818_CR339","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","volume":"107","author":"S Thakkar","year":"2017","unstructured":"Thakkar S, Misra M. Electrospun polymeric nanofibers: new horizons in drug delivery. Eur J Pharm Sci. 2017;107:148\u201367 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717304001.","journal-title":"Eur J Pharm Sci"},{"key":"818_CR340","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107446830","volume-title":"Fundamentals and applications of micro and nanofibers","author":"AL Yarin","year":"2014","unstructured":"Yarin AL, Pourdeyhimi B, Ramakrishna S. Fundamentals and applications of micro and nanofibers. Cambridge: Cambridge University Press; 2014. Available from: http:\/\/ebooks.cambridge.org\/ref\/id\/CBO9781107446830."},{"key":"818_CR341","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11095-015-1769-0","volume":"33","author":"D Carson","year":"2016","unstructured":"Carson D, Jiang Y, Woodrow KA. Tunable release of multiclass anti-HIV drugs that are water-soluble and loaded at high drug content in polyester blended electrospun fibers. Pharm Res. 2016;33:125\u201336 Available from: http:\/\/link.springer.com\/10.1007\/s11095-015-1769-0.","journal-title":"Pharm Res"},{"key":"818_CR342","unstructured":"Novel nanofiber-based technology could help prevent HIV\/AIDS transmission. [cited 2014 Nov 4]. Available from: https:\/\/www.sciencedaily.com\/releases\/2014\/11\/141104183713.htm."},{"key":"818_CR343","unstructured":"Wu Y, Weil T. Nanodiamonds for biological applications. Phys Sci Rev. 2017;2. Available from: http:\/\/www.degruyter.com\/view\/j\/psr.2017.2.issue-6\/psr-2016-0104\/psr-2016-0104.xml."},{"key":"818_CR344","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/dst.2012.0007","volume":"1","author":"LK Moore","year":"2012","unstructured":"Moore LK, Gatica M, Chow EK, Ho D. Diamond-based nanomedicine: enhanced drug delivery and imaging. Disruptive Sci Technol. 2012;1:54\u201361 Available from: http:\/\/online.liebertpub.com\/doi\/abs\/10.1089\/dst.2012.0007.","journal-title":"Disruptive Sci Technol"},{"key":"818_CR345","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41598-017-16703-9","volume":"8","author":"U Roy","year":"2018","unstructured":"Roy U, Drozd V, Durygin A, Rodriguez J, Barber P, Atluri V, et al. Characterization of nanodiamond-based anti-HIV drug delivery to the brain. Sci Rep. 2018;8:1603 Available from: http:\/\/www.nature.com\/articles\/s41598-017-16703-9.","journal-title":"Sci Rep"},{"key":"818_CR346","doi-asserted-by":"publisher","first-page":"012019","DOI":"10.1088\/1742-6596\/345\/1\/012019","volume":"345","author":"VT Ivanova","year":"2012","unstructured":"Ivanova VT, Ivanova MV, Spitsyn BV, Garina KO, Trushakova SV, Manykin AA, et al. Interaction of nanodiamonds materials with influenza viruses. J Phys Conf Ser. 2012;345:012019 Available from: http:\/\/stacks.iop.org\/1742-6596\/345\/i=1\/a=012019?key=crossref.d83b2b535cc4ca7bf683a33aa6646d80.","journal-title":"J Phys Conf Ser"},{"key":"818_CR347","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12951-017-0305-2","volume":"15","author":"NB Pham","year":"2017","unstructured":"Pham NB, Ho TT, Nguyen GT, Le TT, Le NT, Chang H-C, et al. Nanodiamond enhances immune responses in mice against recombinant HA\/H7N9 protein. J Nanobiotechnol. 2017;15:69 Available from: http:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-017-0305-2.","journal-title":"J Nanobiotechnol"},{"key":"818_CR348","doi-asserted-by":"crossref","unstructured":"Zitzmann C, Kaderali L. Mathematical analysis of viral replication dynamics and antiviral treatment strategies: from basic models to age-based multi-scale modeling. Front Microbiol. 2018;9 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01546\/full.","DOI":"10.3389\/fmicb.2018.01546"},{"key":"818_CR349","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12916-019-1314-9","volume":"17","author":"AM Niewiadomska","year":"2019","unstructured":"Niewiadomska AM, Jayabalasingham B, Seidman JC, Willem L, Grenfell B, Spiro D, et al. Population-level mathematical modeling of antimicrobial resistance: a systematic review. BMC Med. 2019;17:81 Available from: https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1314-9.","journal-title":"BMC Med"},{"key":"818_CR350","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12967-017-1224-6","volume":"15","author":"S Jiang","year":"2017","unstructured":"Jiang S, Wang K, Li C, Hong G, Zhang X, Shan M, et al. Mathematical models for devising the optimal Ebola virus disease eradication. J Transl Med. 2017;15:124 Available from: http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1224-6.","journal-title":"J Transl Med"},{"key":"818_CR351","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40249-020-00640-3","volume":"9","author":"T-M Chen","year":"2020","unstructured":"Chen T-M, Rui J, Wang Q-P, Zhao Z-Y, Cui J-A, Yin L. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020;9:24 Available from: https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-020-00640-3.","journal-title":"Infect Dis Poverty"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00818-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00818-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00818-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:20:09Z","timestamp":1744150809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00818-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":351,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00818-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"3 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}